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Enterococci are intestinal facultative anaerobic strains which recognized as 
opportunistic pathogens. The ability to form biofilms is an important 
virulence trait that has been reported for Enterococci. Biofilm formation 
showed differences between E. faecalis strains. However, several factors 
were involved in this process e.g. the presence of virulence factors, 
hydrophobicity and heterogeneity. Interestingly, we demonstrated for the 
first time a biochemical test for a cell surface protein in biofilm formation: 
addition of the purified N domain of Esp (EspN) to E. faecium E1162Δesp 
resulted in the restoration of biofilm formation. 
Streptococcus bovis also, is an intestinal facultative anaerobic bacterium. 
This organism also has been reported as an opportunistic pathogen causing 
multiple diseases such as septicemia and endocarditis associated with 
colorectal cancer (CRC). Although the association of S. gallolyticus 
infection with CRC is a major issue, the mechanisms behind this link are 
still unclear. This link between CRC and the virulence of S. bovis strains 
was studied in more detail in a collaborative project with Dr Harold 
Tjalsma. The Tjalsma group mainly focussed on host-pathogen 
interactions, whereas we analysed biofilm formation of S. bovis strains as 
well as their pathogenicity using the in vivo C. elegans infection model. 
 Our biofilm showed that S. bovis strains form biofilms particularly well on 
collagen-rich surfaces at least indicate why there is this association. C. 
elegans experiments also showed that pathogenicity of S. bovis strains is 
more similar to E. faecalis than to E. faecium in which both S. bovis and E. 
faecalis have a slow mode of killing that is absent in E. faecium. Full 
genome sequences of S. gallolyticus UCN34 strain have revealed the 
presence of a number of potential collagen-binding proteins (e.g., 
gallo_2179) that are related to the MSCRAMMs family. However, we 
successfully cloned the gallo_2179 gene in an enterococcal expression 
vector, and demonstrated transcribed in E. faecalis. Unfortunately, this 
strain did not form better biofilms on a collagen surface, suggesting either 
that not sufficient amount of the protein was made, or that the protein is not 
functional in E. faecalis. In addition, a bioinformatics analysis was 
XIV 
 
performed to identify putatively secreted proteins in S. gallolyticus. 
Proteins that were expected to be found include for instance three collagen-



























Enterococci are facultative anaerobic Gram positive bacteria which usually 
occur in pairs or short chains; they are belong to the group of lactic acid 
bacteria, many of which produce bacteriocins (Fisher and Phillips, 2009). 
Enterococci were initially classified in the genus Streptococcus. When in 
1930 the Lancefield serological typing system was introduced, they were 
put into group D streptococci. However, it was also realized that these 
organisms were somewhat different from other streptococci. For instance, 
they are tolerant to a wider range of adverse conditions and could grow at 
temperatures between 10 to 45˚C, but also survive at a relatively high 
temperature up to 60˚C for 30 minutes, tolerate to grow in 6.5% Sodium 
salt (NaCl), in pH 9.6 and in 40% bile salt. Genomic analysis in the 1980s 
made it clear that these organisms were distinct from streptococci and were 
therefore given the genus name Enterococcus (Fisher and Phillips, 2009; 
Cetinkaya et al., 2000). 
Enterococci are natural inhabitants of the human and animal’s 
gastrointestinal (GI) tract and oral cavity. They also can be found in water, 
soil and plants. In addition, they have been used in food fermentation and 
human probiotics (Franz et al., 1999; Gaspar et al., 2009). However, 
recently Enterococci recognized as an opportunistic pathogens which cause 
disease such as bacteremia, wound infection, endocarditis and pelvic and 
urinary tract infection (Gaspar et al., 2009). 
The most commonly encountered enterococcal species are Enterococcus 
faecalis and Enterococcus faecium, which are responsible for 80-90% and 
10-20%, respectively of human enterococcal infection (Mohamed and 
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Huang, 2007). Importantly, enterococcal infections are particularly 
problematic because of their multiple antibiotic resistance (Cox et al., 
2005).  
 
1.2. Biofilm formation  
 
 A biofilm is a population of cells that adhere irreversibly on a range of 
biotic and abiotic surfaces and which is encased in a matrix of 
exopolymeric substances (EPS; Mohamed and Huang, 2007). In nature, 
bacterial cells exist in biofilms much more frequently than as planktonic 
(free floating) cells.  Also, biofilms can comprise one or multiple species of 
microorganisms (O'Toole et al., 2000, Prakash et al., 2003). Biofilm may 
form on variety of surfaces including living or dead  tissue, indwelling 
medical devices, water pipes, natural aquatic systems and contact lenses 
(Prakash et al., 2003) 
Biofilm-associated cells are physiologically different from planktonic cells. 
This is governed by several features, such as the very slow rate of growth 
of cells within biofilms, a fast genetic exchange, and cell-cell 
communication through quorum sensing. This leads to, for instance, an up 
to 1000-fold increase in antibiotic resistance (Raffa et al., 2005, Donlan, 
2001, Donlan, 2002). In addition, biofilms provides protection for cells 
from environment stress including UV light, antibiotic, shear forces and 
host immune defense (Prakash et al., 2003). 
Resistance against antimicrobial occurs to several reasons. Firstly, EPS act 
as a barrier which prevents the penetration of some of antibiotics.  Also, the 
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negative charge of EPS matrix contributes in antibiotic resistance through 
binding directly to these compounds (Mah and O'Toole, 2001, Donlan, 
2002, Prakash et al., 2003). Secondly, cells within the biofilm are 
characterized by slow growth and therefore have a slow metabolic rate 
which explains their resistance to antibiotics that inhibit processes in 
actively dividing cells, such as cell wall synthesis, or 
transcription/translation. Also, the close proximity of cells within the EPS 
matrix enables conjugation of plasmids, some of which encode genes for 
(multiple) antibiotic resistance. Thirdly, some antibiotics are inactivated in 
the EPS by secreted enzymes such as β-Lactamase (Soto, 2013, Mah and 
O'Toole, 2001). In addition to antibiotic resistance, cells in biofilm are also 
toleratant to host immune defense systems such as phagocytosis, as for 
instance neutrophils are unable to make proper contact and phagocytose 
cells that are embedded in EPS (Prakash et al., 2003). 
Note that biofilm formations also have many beneficial functions in the 
environment. For example, biofilms formed on the Rhizosphere plant roots 
provide water stability for the plant. Also, biofilms are being utilized in 
ground water treatment  with, for instance, contamination from petroleum 
compounds (Davey and O'Toole G, 2000).  
The biological cycle of biofilm development takes place in a series of 
stages starting with  initial attachment, followed by microcolony formation, 






Figure 1.1 simplified model for biofilm formation stages. See text for 
more details. 
 
1.2.1. Initial attachment 
 
Initial attachment of planktonic bacteria to a surface depends on several 
factors including cell surface properties, substratum and environment 
conditions (O'Toole et al., 2000, van Merode et al., 2006b). Bacterial 
adhesion is mediated by electrostatic, Lifshitz- van der Waals, Lewis acid-
base interaction and hydrophobic forces. These interactions along with cell 
surface proteins react to overcome the repulsion of the net negative charge 
surface (van Merode et al., 2006b).  
Several cell surface components have been noted to promote the initial 
adhesion for example, flagella, lipoproteins, polysaccharides and fimbriae 
in Gram negative bacteria whereas autolysin , biofilm associated proteins 
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(BaP) and adhesin in Gram positive bacteria (Hall-Stoodley and Stoodley, 
2002, Lejeune, 2003, Lasa and Penades, 2006). 
Interestingly, several reports have shown that genes encoding some cells 
components such as flagella in E. coli are repressed after attachment as 
these genes are only required in the early stages but are not required in 
development of biofilm, indicating genetic changes during biofilm 
formation (Hall-Stoodley and Stoodley, 2002, Monds and O'Toole, 2009, 
Beloin and Ghigo, 2005).  
Furthermore, the characteristics of the substratum and the medium also 
have an effect on bacterial attachment. It has been shown that bacterial 
attachment is enhanced with increased roughness and hydrophobicity of the 
surfaces (O'Toole et al., 2000). Other environmental factors that can affect 
initial bacterial colonization include flow velocity, pH, nutrient levels, 
cation concentration and temperature (O'Toole et al., 2000, Beloin and 
Ghigo, 2005). In addition, the presence of a conditioning film especially 
with liquid-solid surfaces may alter the surface properties. This film, which 
may contain both organic and inorganic material depends strongly on the 
existing environment (Pringle and Fletcher, 1983). 
 
1.2.2. Microcolony formation and maturation of biofilm  
 
Once bacterial cells attach to the surface irreversibly, more bacteria will 
adhere to the monolayer. Furthermore, as cells on the surface will divide to 
form microcolonies which may contain around 100 cells in a cluster 
(Monds and O'Toole, 2009). 
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At this stage the bacteria start to produce Extracellular polymeric matrix 
(EPS) which facilitates cells adhesion and provides protection against 
antibiotics and host immune defense.  EPS is a very strongly hydrated 
matrix which contains water channels that allow inflow of oxygen and 
nutrients, and outflow of byproducts within the biofilm (Donlan, 2002, 
O'Toole et al., 2000, Molobela et al., 2010). In addition, it provides 
structure to the biofilm. EPS primarily consist of polysaccharides, lipids, 
proteins and extracellular DNA (eDNA; Aguilera et al., 2008, Flemming et 
al., 2007, O'Toole et al., 2000). However, variation in these components is 
governed by several factors including nutrient availability, shear forces, 
temperature and the organism within the biofilm (O'Toole et al., 2000, 
Sutherland, 2001, Donlan, 2002). 
As growth population increased within biofilm the cells density will 
increase allowing cell-cell communication through quorum sensing 
mechanisms. As a result of high cell density, cells release chemical 
signalling molecules, called autoinducers. Once these reach a critical 
concentration, the signals then activate quorum sensing mechanisms to 
regulate genes expression (Raffa et al., 2005, Miller and Bassler, 2001). 
These expression genes have an important role in many processes, 
including further development of biofilms, increased virulence, sporulation, 
protective bioluminescence and competence for the uptake of DNA (Raffa 
et al., 2005, Hancock and Perego, 2004, Dunn and Handelsman, 2002). 
Continuous growth of the cells within the biofilm leads to development of a 
3-dimensional complex biofilm containing macrocolonies that are separated 
by water channels (Hall-Stoodley et al., 2004, Kaplan, 2010). Also, the 
biofilm structure may interact with nonmicrobial particles depending on the 
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environment surrounding the biofilm. For example, biofilms developing on 
heart valves may consist of bacterial cells, EPS, fibrin and erythrocytes, 
which the latter may protect the biofilm from host defense such as 
leukocytes. If such colonization is indeed not cleared it results in infective 
endocarditis, a potentially dangerous disease (Donlan, 2002, Durack, 1975).  
 
1.2.3. Biofilm detachment  
 
Microbial cells in biofilm may disperse either in individual colonies or as a 
small portion of the biofilm (shearing dispersal), a mechanism which could 
be either passive or active. Active biofilm dispersal is initiated by the 
microbial cells themselves, by for instance release of molecules such as D-
amino acids or polyamines (Kolodkin-Gal et al., 2012). Passive dispersal is 
mediated by signals in the biofilm, environmental changes or physical 
forces (Kaplan, 2010, Donlan, 2002). Factors induce detachment of biofilm 
include changing in nutrient and oxygen level, pH, temperature, quorum 
sensing, EPS degrading enzymes and various signalling molecules such as 
nitric oxide (Kaplan, 2010, Karatan and Watnick, 2009).   
Physical dispersal has been classified into three processes: shearing, 
abrasion and sloughing dispersal. Shearing dispersal is removing of small 
biofilm portion due to the stress of the fluid flow on the surface. Abrasion 
removal when particles of biofilm colloid in the fluid bulk causing detach 
of the biofilm. The third type of biofilm dispersal called sloughing happens 
when there is nutrient or oxygen depletion, leading to detachment of larger 
chunks of the biofilm that can colonize other surfaces and start another 
9 
 
biofilm cycle, or develop as planktonic type bacteria (Choi and 
Morgenroth, 2003, Stoodley et al., 2001, Donlan, 2002). 
 
1.2. Antibiotic Resistance in Enterococci  
 
The mechanisms by which enterococci can resist multiple antibiotics have 
been categorized into two mechanisms: (i) intrinsic resistance to vary of 
antibiotics (ii) acquired resistance including the ability to transfer this 
resistance to the other species (Mundy et al., 2000). 
Intrinsic resistance depends on the innate ability of bacteria to tolerate 
antibiotics and can depend on e.g.  poor penetration of antibiotics into the 
cell or lack of a target for an antibiotic (Jankoska et al., 2008). In the case 
of enterococci, cells contain penicillin binding proteins (PBPs) which have 
a low affinity to several β-lactams antibiotics such as penicillin and 
cephalosporins. This resistance is in particular due to production the low-
affinity of PBP5 (Cetinkaya et al., 2000). Enterococcal resistance to β-
lactams is varies, but the lowest resistance is for in particular ampicillin 
(Cetinkaya et al., 2000). 
Enterococci also have resistance to aminoglycosides either moderate 
resistance due to poor permeability or high resistance due to production of 
inactivating enzymes (Cetinkaya et al., 2000). Enterococci resistance to 
aminoglycosides depends on the production of the inactivating enzyme. For 
example, strains that produce a bifunctional enzyme such as 2”-
phosphotransferase-6’-acetyltransferase mediates high level resistance to 
gentamicin, kanamycin and amikacin.  
10 
 
Strains producinge 3’-phosphotransferase-III are also resistant to 
kanamycin, but more susceptible to gentamycin. Also, some strains are 
resistant to streptomycin through production of streptomycin 
adenyltransferase (Herman and Gerding, 1991), but these are still 
susceptible to gentamycin (Herman and Gerding, 1991, Cetinkaya et al., 
2000). Therapeutic combination of aminoglycosides and β-lactams or 
glycopeptides (cell wall synthesis inhibitor) may overcome the tolerance 
against aminoglycosides (Cetinkaya et al., 2000).  
Enterococci can acquire antibiotic resistance through either exchange of 
resistance genes carried on a plasmid or transposon, or via mutation 
(Cetinkaya et al., 2000). Innate low ampicillin resistance through 
production of low affinity PBP5s has previously been mentioned. High 
ampicillin resistance usually refers to acquired resistance obtained through 
one of two mechanisms. Firstly, in most cases in E. faecalis there is 
production of β-lactamases, which were originally acquired from the S. 
aureus β-lactamase operon (Rice, 2001, Rice and Marshall, 1992). 
Secondly, mutations or alterations in the amount of production of PBP5s 
can also lead to high level resistance. An increase in the expression genes 
encoding PBP5s is most commonly found in E. faecium (Cetinkaya et al., 
2000, Grayson et al., 1991). 
 
1.3. Vancomycin resistance Enterococci (VRE)  
 
Vancomycin resistance enterococci (VRE) were first reported in Europe 
during mid-1980s. VRE initially disseminated in Europe when an analogue 
drug for vancomycin (Avoparcin) was widely used in farm animals, which 
11 
 
attributed in community-acquired vancomycin resistance. In contrast, in the 
US no glycopeptides have been used in farms. However, the great use of 
vancomycin in hospitals leads to the emergence of VRE even though they 
do not have reservoir of VRE among the community (Tacconelli and 
Cataldo, 2008, Stobberingh et al., 1999, Mascini and Bonten, 2005). 
Nowadays, VRE is causing clinical problems and a major concern in 
medical practice due to the ability to transfer the vancomycin resistance 
across other bacteria such as methicillin resistance Staphylococcus aureus 
(MRSA; Zirakzadeh and Patel, 2006), for which vancomycin is one of the 
few “last-resort” treatment options. 
Vancomycin act as a cell wall synthesis inhibitor through it is binding to 
the D-alanyl-D-alanine (D-ala-D-ala) the terminus of peptidoglycan 
precursor, which inhibits attachment of the transglycosylase enzyme to the 
peptidoglycan precursor (Arthur and Courvalin, 1993). There have been 
described six phenotypes of vancomycin resistance; VanA, VanB, VanC, 
VanD, VanE and Van G (Reynolds and Courvalin, 2005). 
The resistance mechanisms occurs when the terminal residue of the 
peptidoglycan precursor D-alanine is replaced either by D-lactate(D-lac) 
which present in VanA, VanB and VanD, or by D-serine (D-ser) which 
present in VanC, VanE and VanG (Reynolds and Courvalin, 2005). 
Another resistance mechanism is elimination of the target residue with two 
enzymes D,D-carboxypeptidase or/and D,D-dipeptidase leading to remove 
C-terminal D-Ala (Reynolds et al., 1994).  
Among several types of Vancomycin resistance in enterococci, VanA and 
VanB are the most common cause of clinical problems due to their ability 
to transfer to other bacteria (Cetinkaya et al., 2000, Sood et al., 2008) . 
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VanA induces high resistance against vancomycin and teicoplanin, whereas 
VanB is resistant to vancomycin only (Sood et al., 2008).  However, both 
phenotypes are acquired and present in E. faecalis and E. faecium (See 
table 1.1). The other phenotypes are also all acquired except VanC. The 
latter is also found in other enterococci such as E. gallinarum, E. 
casseliflavus and E. flavescons, whereas VanD is found in E. faecium, and 
VanE and VanG in E. faecalis (Sood et al., 2008, Zirakzadeh and Patel, 
2006, Cetinkaya et al., 2000). 
 
Table 1.1 characteristics of VRE phenotypes. 
                                       Phenotypes 
Characteristic  VanA VanB VanC VanD VanE VanG 
Vancomycin R R R R R R 
Teicoplanin R S S S S S 
Genetic -
determination  
Acquired  Acquired. Intrinsic Acquired. Acquired. Acquired 
Transferable  Yes Yes No No No No 
Enterococci 








 E. flavescons 








1.4. Pathogenicity and Virulence of Enterococci 
 
As mentioned previously, enterococci are found in the gastrointestinal (GI) 
tract as a part of the gut flora and they are normally harmless. However, 
during the last few decades enterococci have become a major cause for a 
variety of human infections (Jett et al., 1994).  
Virulence of enterococci species  is mediated by many factors, including 
their ability to colonize the GI tract and adherence to the extracellular 
matrix proteins (such as collagen) and epithelial cells (Fisher and Phillips, 
2009). In addition, using broad spectrum antibiotics contribute intestinal 
overgrowth of enterococci, which then leads to their colonizing and 
translocation through the epithelial cells to the liver and spleen. 
Dissemination of enterococci may cause several serious infection such as 
bacteremia and endocarditis (Jett et al., 1994). 
Several enterococcal virulence factors have been reported to have important 
roles in biofilm development and pathogenesis of E. faecalis, including cell 
wall adhesion proteins and secreted proteins (Pires-Boucas et al., 2010). 
These include for instance, aggregation substance AS, Enterococcal surface 
protein Esp, E. faecalis endocarditis associated antigen A (EfaA), adhesion 
of collagen of E. faecalis Ace, gelatinase GelE and the toxin Cytolysin (see 
table 1.2). 
Adhesion to host extracellular matrix components (ECM) is the first step 
for pathogens to mediate infection. This is important in promoting 
enterococci to colonize host vascular tissues through interactions between 
enterococcal surface proteins and host proteins such as collagen and 
laminin. In fact, many studies have reported surface proteins containing an 
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immunoglobulin-like fold which are named MSCRAMMs (Microbial 
Surface Components Recognizing Adhesive Matrix Molecules; 
(Nallapareddy and Murray, 2006). Indeed, many well-characterized surface 
proteins in Gram-positive bacteria (such as streptococci, staphylococci and 
enterococci) are MSCRAMMS (Walsh et al., 2008, Sillanpää et al., 2009). 
These proteins share several characteristics including an N-terminal signal 
peptide sequence followed by an A-domain which consist of one or 
multiple subdomains, each of which adopt a IgG-like fold (immunoglobulin 
G-like). Following the A-domain is a series of repeated sequences that is 
referred to as the B-domain. The C-terminal has a so-called LPXTG motif 
which is required for cell wall anchoring that is accomplished by a specific 
enzyme called a sortase (Hendrickx et al., 2009, Liu et al., 2007). 
E. faecalis Ace shares sequence similarity with S. aureus MSCRAMM 
Cna. Characteristics of these proteins including an N-terminal signal 
peptide followed by A-domain then B-domain and C-terminal. Based on 
the studies on S. aureus Cna, it was shown that the collagen-binding 
activity is located in the A-domain (Hendrickx et al., 2009, Liu et al., 
2007).  Ace has been reported to contribute in pathogenicity in a rat 
endocarditis model and it has been demonstrated that during endocarditis 
there is a higher level of ace expression than in laboratory conditions 
(Singh et al., 2010). Also, the same study confirmed inhibition of E. 
faecalis collagen adherence by using active and passive immunization 
based on the collagen binding domain of Ace. Thus, this study did not only 
indicate the importance role of this protein in endocarditis, but also showed 
promising therapeutic strategies against E. faecalis endocarditis. 
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AS is an E. faecalis surface-anchored protein which is encoded by 
pheromone-responsive plasmids (Dunny, 1990). It facilitates transfer of 
plasmids between cells by allowing the adherence of the donor bacterium 
cells to recipient cells (Dunny, 1990). In addition, aggregate substances 
mediate adherence into renal and intestinal epithelial cells and cardiac 
vegetation and also, enhance biofilm formation by cell aggregation (Kreft 
et al., 1992, Chow et al., 1993).    
Enterococcal surface protein Esp is a cell wall protein. Studies observed an 
association of Esp in the initial attachment and biofilm formation of E. 
faecalis on abiotic surfaces (Toledo-Arana et al., 2001). Furthermore, it has 
been shown that Esp promotes the colonization and persistence of E. 
faecalis in urinary tract infection in animal model (Shankar et al., 2001). 
E. faecalis endocarditis antigen A (EfaA) amino acid sequence analysis 
showed 55% to 60% similarity to a group of streptococcal proteins (FimA 
from Streptococcus parasanguis, SsaB from Streptococcus sanguis, ScaA 
from Streptococcus gordonii, and PsaA from Streptococcus pneumonia), 
which have been shown to be involved in adhesion in endocarditis (Lowe et 
al., 1995). A study using a peritonitis mouse model, mice injected with an 
E. faecalis mutant lacking efaA showed prolonged survival compared to 
mice injected with wild type E. faecalis, suggesting an important role of 
EfaA in disease (Singh et al., 1998a). 
GelE is a secreted zinc-metalloprotease (gelatinase) that shares similarity 
with P. aeruginosa Elastase and S. aureus Aurolysin (Potempa and Pike, 
2009). Its gene, gelE is an operon with the serine protease sprE with the 
latter located immediately downstream from gelE (Gaspar et al., 2009).  
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GelE and SprE expression is controlled by the fsr (faecal streptococci 
regulator) locus, which contains four genes: fsrA, fsrB, fsrC and fsrD. 
These genes are part of a quorum sensing two-component system (Sava et 
al., 2010, Fisher and Phillips, 2009). As mentioned previously, activation of 
this system will lead to up- and down-regulation of the expression of other 
genes, and this happens when the concentration of the autoinducer peptide 
outside the cell reaches a minimum threshold (quorum) level that is usually 
only reached at high cell densities. 
Gelatinase biosynthesis-activating pheromone is an autoinducer peptide 
encoded by fsrD. FsrB is responsible of exporting and cyclization of this 
FsrD peptide. Accumulation of the peptide in the extracellular space can be 
sensed by histidine kinase sensor FsrC leading to activation of the response 
regulator FsrA (Sava et al., 2010, Thomas et al., 2008). This process then 
results in the expression of GelE and SprE, which are located downstream 
from fsr locus.   
Gelatinase is able to degrade several substrates such as casein, gelatin, 
fibrin and other immune peptides (Thurlow et al., 2010). Also, GelE has 
been shown to have a role in development of biofilms of E. faecalis 
(Hancock and Perego, 2004). The mechanism by which GelE contributes in 
biofilm formation is unknown. However, there are a number of theories of 
how GelE promotes biofilm formation, one being that GelE increases cell 
surface hydrophobicity by cleaving cell surface proteins at hydrophobic 
residues and therefore, enhanced cell attachment to the surface (Carniol and 
Gilmore, 2004). Several studies have reported a reduction in biofilm 
formation of E. faecalis mutant lacking gelE (Thomas et al., 2008, 
Mohamed et al., 2004). Also, GelE has been shown to contribute to 
17 
 
virulence in mouse models in peritonitis, endocarditis and endophthalmitis 
(Singh et al., 2005, Singh et al., 1998b, Engelbert et al., 2004). 
Cytolysin or hemolysin are other secreted proteins which are related to S. 
pyogens streptolysin (Cox et al., 2005). Production of these lytic enzymes 
involves several genes that are encoded either on a plasmid or on the 
chromosome (Haas et al., 2002). Cytolysin is expressed as two peptide 
subunits, CylLL (the long subunit) and CylLS (the small subunit). 
Production and activation of cytolysin involves several stages. The two 
subunits LL and LS are synthesized ribosomally and then post-
translationally modified by the protein CylM. Next, the modified peptides 
are proteolytically cleaved and secreted from the cell by CylB (an ABC 
transporter). The secreted peptides are then activated by further cleaved by 
CylA (a serine protease). Cells producing cytolysin could be protecting 
themselves by CylI which is located in the cell wall. Production of 
cytolysin is regulated by CylLs, which can can interact with the regulatory 










Table 1.2 Summary for E. faecalis virulence factors. 
Virulence factor Role in virulence 
Surface associated proteins  
AS • Biofilm formation 
• Adhesion and invasion of 
endothelium cells 
• Attachment to ECM 
Esp • Biofilm formation 
• Endocarditis and Urinary 
tract infection 
EfaA • Experimental peritonitis 
Ace (MSCRAMMs) • Attachment to ECM 
• Endocarditis  
Secreted proteins  
GelE and SprE • Biofilm formation 
• Experimental endocarditis, 
peritonitis and endophthalamitis 
• Virulence in C. elegans 
Autolysin • Biofilm formation 
Cytolysin • Tissue damage 
• Virulence in C. elegance 
• Experimental endocarditis 
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1.5. Streptococcus bovis  
 
Streptococcus bovis is a facultative anaerobic, spherical and Gram positive 
lactic acid bacterium (Herrera et al., 2009). S. bovis belongs to the group D 
streptococci based on its cell wall polysaccharide antigen (Lancefield, 
1933). These bacteria are considered as normal flora in both animal and 
human GI tract (Herrera et al., 2009). However, S. bovis has been 
implicated in several human diseases such as bacteremia, meningitis and 
endocarditis (Songy et al., 2002, Gavin et al., 2003). In addition, S. bovis 
can cause disease to animals including septicemia in pigeons, bovine 
mastitis and acute acidosis, bloat and liver abscesses in ruminants (Rusniok 
et al., 2010, Herrera et al., 2009).  
Multiple studies showed the association between S. bovis and colon cancer 
in humans, with the first study already being published in 1951 (McCoy 
and Mason, 1951). However, the mechanisms behind this link still unclear 
(Rusniok et al., 2010). The association may simply be that alteration of the 
environment in the colon due to a tumour provides a niche more suitable to 
colonization, which then leads to translocation of the pathogens into blood 
stream. This, in turn, can then result in other diseases such as endocarditis. 
Indeed, there is a very high risk of patients with S. bovis endocarditis also 
having colon cancer (Boleij et al., 2011b).   
Another option on the link between colon cancer and S. bovis may be that 
the organism exacerbates tumour development. Indeed, it has been 
suggested that it contributes in carcinoma by stimulation the COX2 
cyclooxygenase 2 pathway resulting in cell proliferation (zur Hausen, 2006, 
Tjalsma et al., 2006). The final option is that S. bovis causes of colon 
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cancer. Bacteria causing cancer is not unprecedented as, for instance, 
Helicobacter pylori appears to be the cause of gastric adenocarcinoma and 
was declared a human carcinogen in 1994 (McColl, 2010). However, there 
is at present no clear evidence that S. bovis is the cause of colon cancer. 
Recently, S. bovis has been divided into four biotypes(see chapter 6 for 
details; (Schlegel et al., 2004). One of the species is S. gallolyticus which 
belongs to S. bovis biotype I (mannitol fermentation positive). The name 
gallolyticus refer to its tannase activity and therefore, decarboxylate gallate 
which is a derived organic acid from tannin degradation (Rusniok et al., 
2010). Also, S. gallolyticus be able to express bile salt hydrolase and 
amylase (Chamkha et al., 2002). The aforementioned association between 
S. bovis infections and colon cancer appears to be clearly linked to this 
biotype I. It was shown that association between S. bovis type I and 
bacteremia and endocarditis is 94%, and that this is 71% with bacteremia 
and colon cancer. In contrast, the association of S. bovis biotype II is only 
18% with bacteremia and endocarditis, and 17% with bacteremia and colon 
cancer (Ruoff et al., 1989). 
Studies on S. gallolyticus virulence factors are still largely unknown. 
However, a study on S. gallolyticus strain isolated from pigeon have 
described five serotypes and shown that these species all produced a 
polysaccharide capsule (De Herdt et al., 1992). Also, electro-
microscopically studies on S. gallolyticus isolated from pigeons showed the 
presence of capsule and pili structure which been hypothesized to be 
involved in virulence (Vanrobaeys et al., 1999). Further evidence on factors 
playing a role in pathogenicity is presented in chapter 6, whereas some 
potential extracellular virulence factors are identified in chapter 3. 
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Similar to other Gram positive bacteria including staphylococci, 
streptococci and enterococci, S. bovis can mediate endocarditis by its 
ability to adhere to ECM proteins (Sillanpaa et al., 2008). A study on S. 
gallolyticus isolated from human with endocarditis identified indeed the 
presence of collagen binding protein Acb (adhesion to collagen of S. bovis) 
and other ECM binding proteins (Sillanpää et al., 2009). Furthermore, a full 
genome analysis of S. gallolyticus UCN34 strain isolated from human with 
endocarditis associated with colon cancer revealed the existence of capsular 
polysaccharides, pili and ECM binding proteins (Rusniok et al., 2010). The 
presence of capsules may provide protection for the pathogen from immune 
host defense and cell surfaces proteins contribute in bacterial adhesion to 
host tissues (Rusniok et al., 2010).  
 
1.6. The aims of this thesis 
 
Enterococci have became a major clinical problem because of their 
antibiotic resistance and ability to transfer resistance genes among other 
bacteria. The first part of this thesis is to study and identify virulence 
factors and properties in particularly E. faecalis strains. Our aim was to 
characterise in particular three clinical isolates from biliary stents that 
differed in the presence of a few critical virulence factors that have been 
mentioned above (Esp, GelE and AS). The genomes of these strains have 
not been sequenced, and these studies aimed in testing a number of factors, 
including testing the presence or absence of further virulence factors, 
pathogenicity and biofilm formation. In addition, we analysed the role of 
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Esp in biofilm formation, mainly using an E. faecium strain for which an 
esp mutant is available.  
The second part was to examine the ability of several S. bovis isolates to 
form biofilms and factors that play a role in that. We were in particular 
interested in the role of the presence of collagen in this process, as some of 
the isolates are associated with diseases such as endocarditis or colon 
cancer. Collagen is a major constituent of heart valves, whereas it may also 
be exposed on tumours in the colon. Furthermore, using bioinformatics we 
analysed the (putative) secretome of S. bovis; as some of the proteins in this 
secretome may indeed represent (novel) virulence factors. Finally, 




















All chemicals and bacteriological media used in this study were purchased 
from Sigma-Aldrich, Oxoid or Fisher Scientific, unless noted otherwise. 
Custom oligonucleotides were synthesized by Sigma-Aldrich.  
2.2. Bacterial strains and growth conditions 
 
Bacterial strains and plasmids used in this study are listed in table 2.1 and table 
2.2. Enterococcus and Streptococcus strains were cultured in Brain Heart 
Infusion (BHI) or Tryptone-soya-broth (TSB). For biofilm assays, TSB 
supplemented with 0.25% glucose (TSB-G) was used. For pathogenicity 
testing, strains were cultured in BHI agar supplemented with the appropriate 
antibiotics. E. coli strains (OP50, HB101 and BL21 (DE3)) were maintained 
on Luria-Bertani (LB) medium. For assays involving nematodes (section 2.7), 
nematode growth medium (NGM) agar plates were used for growth of E. coli 
(Brenner, 1974).E. coli BL21 (DE3) was grown in Luria-Bertani Medium (LB) 
supplemented with Kanamycin (50 µg/ml). Spectinomycin (60 µg/ml) and 
Chloramphenicol (5 µg/ml), were added to LB medium to prevent the loss of 









Table 2.1 a list of bacterial strains used during this project. 
Strains Important characteristics  Reference 
E.  faecalis: 
BS12297 
 
Isolate from clogged biliary stents. 
Esp+, GelE- 
(van Merode et al., 2006b) 
 
BS11297 Isolate form clogged biliary stents. 
Esp+, GelE+ 
(van Merode et al., 2006b) 
BS385 Isolate form clogged biliary stents. 
Esp-, GelE- 
(van Merode et al., 2006b) 
E. faecalis ATCC 
19433 





Clinical Blood isolate (CC17). AmpR, 
Esp+ 
(Thomas et al., 2008) 
E1162Δ E1162 strain with esp gene deleted (Thomas et al., 2008) 
TX1130 Healthy volunteer faecal isolate. 
AmpS, Esp- 
(Lasa and Penades, 2006) 
S. bovis: 
SB1293 
Biotype I (gallolyticus subsp. 
gallolyticus) 
H. Tjalsma (Nijmegen) 
SB1294 Biotype II/2 (S. gallolyticus subsp. 
pasteurianus) 
H. Tjalsma (Nijmegen) 
NTCT8133 Biotype II/1 (S. infantarius) H. Tjalsma (Nijmegen) 
S. macedonicus  H. Tjalsma (Nijmegen) 
S. gallolyticus 
NTB1 
Biotype I (S. gallolyticus subsp. 
gallolyticus) 
H. Tjalsma (Nijmegen) 
   S. gallolyticus 
UCN34 
Biotype 1(S. gallolyticus subsp. 
gallolyticus) 




- Abbreviation: gelatinase E (gelE), enterococal surface protein (esp), AmpR 
(ampicillin resistance), glp-4, sek-1 (MAPK kinase deficiency and temperature-








WCFS1 (Kleerebezem et al., 2003) 
Salmonella 
typhimurium NTB6 
Clinical isolate, Radboud collection H. Tjalsma (Nijmegen 
C. elegans AU37 (glp-4, sek-1) CGC(CaenorhabditisGeneticsCenter ) 
Escherichia coli 
E. coli OP50 
 
Standard strain to maintain C. elegans  
 
CGC (Caenorhabditis Genetics Center ) 
Eschericia coli 
NTB5 
Clinical isolate, Radboud collection H. Tjalsma (Nijmegen 
E. coli BL21 (DE3) F– ompT gal dcm lon hsdSB(rB- mB-) 
λ(DE3[lacI lacUV5-T7 gene 1 ind1 
sam7 nin5]) 
(Studier and Moffatt, 1986) 
E. coli HB101 F- mcrB mrr hsdS20(rB- mB-) recA13 
leuB6 ara-14 proA2 lacY1 galK2 xyl-5 
mtl-1 rpsL20(SmR) glnV44 λ- 




For routine cloning Novagen 
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Table 2.2 a list of plasmids used during this project. 
 
2.3. Biofilm formation assay 
 
   2.3.1. Crystal violet biofilm assay 
 
Biofilm formation assays were essentially performed as described before with 
some minor modifications (Heikens et al., 2007). Strains were grown overnight 
in TSB-G broth at 37oC. Next day the cultures were diluted in TSB-G to 107 
cfu/ml and dispensed in 96-well microtiter plate (Costar). Next, the microtiter 
plates were incubated at 37oC for 24 hours on 3D plate rotator (Grant-Bio; 
30prm). After that the cell suspension was removed and the plates were 
washed twice with 0.9% NaCl and inverted to dry at room temperature for 1 
hour. Following this 150 µl of crystal violet solution (CV; Prolab Diagnostics) 




E. coli shuttle vector containing OriR from 
pAMβ1, Spcr, lacZ,P2 and catr   
 
(Depardieu et al., 2003) 
pAT-gallo2179 
 
pAT79 containing collagen-binding protein 




pET28a Km, oriR pBR322, origin f1, promoter T7, 




pET-Esp-n N-terminal domain Esp in pET28a This study                                                     
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was added to the wells and was allowed to stain for 15 min. After staining, CV 
was removed and the wells were washed 3 times with 0.9% NaCl. The bound 
CV was then solubilized by adding 200 µl of ethanol-acetone (80:20 v/v). The 
absorbance of CV was read at 595 nm on the plate reader (Versa max Tunable 
microplate reader). 
To test effect of various compounds on biofilm formation, 100 µl of cells were 
mixed with 100 µl of the relevant compound diluted in TSB-G to the relevant 
concentration.  
For biofilm formation on collagen-coated plates, the assays were performed 
similarly to the crystal violet assay except that the assay was either performed 
in pre-coated 96-well microtiter plates (coated with collagen I or collagen IV; 
Becton Dickinson, Bio-Coat), or by using “home-made” coated plates. In case 
of the latter, 64 µl of rat tail collagen or 100 µl, 100 µg/ml, of collagen I 
(Sigma) was added in the wells of a microtitre plate, and the plate was left 
overnight at 25oC in a laminar flow hood. Next day, the plates were rinsed with 
Phosphate buffered saline (PBS; 8g/l NaCl, 0.2g/l KCl, 1.44g/l Na2HPO4, 








2.3.2. Confocal laser scanning microscopy (CLSM) 
 
Bacteria were grown in TSB containing 0.25% glucose overnight at 37ºC. Next 
day the cultures were diluted in TSB-G to 107cfu/ml. Sterile coverslips 
(polyvinyl; Fisher Scientific) were placed in each well of a 6-well plate and 
then 2 ml of diluted culture plus 2 ml TSB-G medium was added. Biofilms 
were then grown on the coverslips for 24 hours at 37ºC on a 3D rotator (30 
rpm). Next, coverslips were removed and washed twice with 0.9% NaCl. 
Finally, the coverslips were transferred to a 55 mm petri dish. 800 µl of Syto9 
stain (Sigma) was added to each coverslip and stained in the dark for 10 
minutes before being washed as described above.  
To visualise biofilm formation on a collagen-coated surface, coverslips were 
covered with collagen in 0.1 M acetic acid, similar as described in section 
(2.3.1), and left overnight at room temperature in a laminar flow hood. Next 
day the coverslips were washed three times with PBS to remove the excess 
acetic acid. Biofilms were then grown on the coverslips as described above. 
Images were collected using LSM510META Zeiss confocal laser scanning 
microscope, laser including the argon laser and the helium laser with wave 







2.4. Protease assay 
   2.4.1. Azocasein assay  
 
This assay was done as described by (Denkin and Nelson, 1999) with some 
modifications. Bacteria were cultured at 37oC overnight in BHI, The following 
day the culture suspensions were centrifuged for 10 minutes at 2,500 g and the 
cell pellet was discarded. 150 µl of the supernatant was added to 250 µl 2% 
azocasein in PBS and incubated for 2 hours at 37oC . Next, the assay was 
terminated by adding 1.2 ml 10% trichloroacetic acid (TCA). An enzyme blank 
was prepared by mixing buffer, enzyme, TCA and the substrate in the same 
order. Next, the samples were centrifuged for 10 minutes at 5000g , and 1.2 ml 
from the supernatant was added to 1.4 ml 1M NaOH, followed by measuring 
the absorbance at 440 nm. 
     2.4.2. Milk – TSB agar method  
 
This has been done by spot around 5 µl of an overnight bacterial culture on a 
TSB-agar plate supplemented with 1%-1.5% of skim milk(Thomas et al., 
2008), followed by incubation at 37oC for overnight.  
 
2.5. Minimum inhibitory concentration (MIC) tests 
 
The MIC test was done as described by (Andrews, 2001). In a 96-well 
microtiter plate 100 µl of the compound to be tested (0.5-512 µg/ml) was 
mixed with 100 µl of medium containing 105 cells/ml and then the plate was 
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incubated for 18 hours at 37oC. The MIC is defined as the lowest concentration 
without visible growth. 
 
2.6. Cell surface hydrophobicity determination 
 
This test was adapted from (Tendolkar et al., 2004). Bacterial strains were 
grown overnight in TSB-G at 37oC containing the compound. The next day the 
culture was diluted 1:50 in 5 ml fresh media and the culture then incubated for 
4 hours at 37ºC. Next, 1 ml of the culture was centrifuged to harvest the 
bacteria. The bacterial pellet was washed twice with 1.2 ml PUM buffer (0.15 
M potassium phosphate, 0.3 M urea, 6.7 mM MgSO4, pH 7.1) and then 
resuspended in 1.2 ml PUM buffer. The optical density was adjusted to 1 OD 
at 400 nm. 200 µl of n-hexadecane was added and the suspension was mixed 
and incubated for 10 minutes. The absorbance of the aqueous layer was 
measured at 400 nm. The percentage hydrophobicity was calculated by using 
the following formula: [1-(final OD400/ initialOD400)] *100 
 
2.7. Nematode killing assay 
 
C. elegans strain AU37 was maintained and propagated on E. coli OP50 as 
previous described by(Brenner, 1974) with some modifications. For infection 
with enterococci or streptococci, antibiotics were added to the BHI medium to 
prevent growth of E. coli. Kanamycin (30 µg/ml) was used with all E. faecalis 
strains and S. bovis strains. 
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 Erythromycin (4 µg/ml) was used for E. coli NTB5, and streptomycin was 
used with E. coli HB101 and Salmonella typhimurium NTB6. For age 
synchronisation, eggs were collected by treatment of gravid adults with bleach 
solution (1 ml bleach - 5% hydrochlorite - plus 0.5 ml 5M NaOH). Eggs were 
washed with M9 buffer and incubated in tube on rotary mixer for overnight at 
room temperature. Next day, the L1 larvae were deposited on NGM plates with 
E. coli HB101 and grown for 48-52 hours. Between 20 and 30 C. elegans L4 
or young adult hermaphrodites were transferred from a lawn of E. coli HB101 
to a lawn of the bacterium to be tested and incubated between 8-12 hours at 
25°C and for anaerobic killing assays bacteria were grown on plates in 
anaerobic GasPak (Becton Dickinson) before starting the experiment. Infected 
worms were then washed and transferred into a well of a 12-well plates, with 
each well containing 1:10 BHI (diluted in M9 buffer) with an appropriate 
antibiotic. Animals were examined for 7 days with a dissecting microscope for 
viability. Worms were considered dead when they did not respond to touch 
with a platinum wire pick. Each experimental condition was tested in 
triplicate(Jansen et al., 2002). 
 
2.8. DNA techniques 
 
     2.8.1. Plasmid purification  
 
Plasmids were isolated using the Nucleospin Plasmid Kit (Macherey-Nagel) by 




     2.8.2. Chromosomal DNA extraction  
 
DNA of Gram-positive bacteria was extracted by phenol method as described 
before by(Shankar et al., 1999) with some modifications. Bacterial strains were 
grown overnight in BHI supplemented with 2.5% glycin at 37°C, and the next 
day cell pellets obtained by centrifugation were suspended in 1 ml TES (50 
mM NaCl, 100 mM Tris, 70 Mm EDTA) containing 25% sucrose plus 100 µl 
lysozyme (10 mg/ml) and 50 U mutanulysin. This was incubated for 2 hours at 
37°C. Next, 20 µl of proteinase K (20 mg/ml) and 50 µl of 10% SDS were 
added, and the samples were incubated for another hour at 55°C. After the 
cells lysed, DNA was purified by adding one volume of phenol-chloroform–
isoamylalcohol (25:24:1), followed my mixing and centrifugation for 5 min at 
10,000g. The top layer was removed and extracted with 
phenol/chloroform/isoamylalcohol twice more. The DNA was precipitated by 
adding 0.1 volumes of 3M Na acetate and 0.6 volume of isopropanol 
centrifugation at 12,000g 1minute. Finally, the DNA pellets were washed with 
80% ethanol, dried at room temperature and resuspended in 150 µl TE buffer 
(10 mM Tris/HCl, 1 mM EDTA pH 8). 
 
    2.8.3. Polymerase chain reaction (PCR) 
 
PCR was performed with an Eppendorf Mastercycler gradient machine 
(Eppendorf). PCR reactions were set-up using either Taq One polymerase 
(New England Biolabs) or KAPA2G robust (KAPA biosystems) by following 
manufacturer’s instructions. The primers used for PCR are listed in table 2.3. 
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Table 2.3 Primersa used in this study. 
aThe restriction sites used for cloning are indicated in bold and underlined 
(XbaI/HindIII for GelE and XbaI/SacI  and BamHI/SalI for Streptococcus bovis 
collagen binding proteins. gelatinase E (gelE), enterococal surface protein (esp), N-
terminal of esp (espN) endocarditis specific protein (efa), collagen binding protein 
(ace), cytolysin transport protein (cylB), cytolysin immunity protein (cylM), 

















































    2.8.4. Restriction enzyme digestion  
 
Restriction enzymes were purchased from New England BioLabs, and 
performed as recommended by the manufacturer. Enzymes used were: SacI, 
XbaI, HindIII and BamHI. DNA and plasmid were digested overnight and 
cleaned up using the Nucleospin Extract II Kit (Macherey-Nagel). 
 
   2.8.5. Ligation  
 
DNA was ligated in to a digested vector using T4 ligase enzyme (New England 
Biolabs). Ligation reactions were set up following manufactures instructions 
and the reaction were incubated overnight at room temperature. 
 
   2.8.6. Agarose gel electrophoresis and Gel purification  
 
Agarose gel electrophoresis was performed as described by (Sambrook and 
Russell, 2001).The 0.8% agarose gel stained with Ethidium bromide was run at 
100V and DNA was photographed under UV light. DNA gel purification was 









     2.8.7. Transformation of bacteria 
 
         2.8.7.1. Transformation of E. coli  
 
NovaBlue GigaSingles compentent cells (Novagen) were transformed with 
plasmids or ligation mixtures according to the manufacturer’s instructions. 
        2.8.7.2. Enterococci and Streptococci Transformation 
 
Preparation of electrocompetent cells from enterococci and streptococci was 
performed as described by (Dunny et al., 1991), using a Bio-Rad 
electroporator. 5 µl of DNA was mixed with 100 µl of thawed cells. Cells were 
left on ice for 5 minutes, transferred into a 1 mm electroporation cuvette, and 
then pulsed at 1.25 kV. Cells were immediately diluted with Todd Hewitt 
Broth medium (THB) containing 0.5 M sucrose and then incubated at 37°C 
between 1.5-2 hours. Finally, 100 µl and 50 µl of these transformed cells were 
plated on THB agar with 20% sucrose containing the appropriate antibiotics 
and incubated for overnight at 37ºC. 
 
     2.8.8. Automated DNA sequencing 
 
Eurofins MWG Operon, UK performed Samples sequencing. For sample 
preparation, 150 ng/μl of plasmid DNA and 15 pmols of primer were mixed in 





2.9. Protein expression and purification 
 
    2.9.1. Induced expression of esp-n in E. coli cells  
 
E. coli BL21 (DE3) cells containing plasmid pET-Esp-n were grown in LB 
medium supplied with 50 µl kanamycin until an OD600 of 0.4. 1 mM 
Isopropyl β-D-thiogalactopyranoside (IPTG) was added and cells were grown 
for a further two hours at 37ºC. Cells were harvested by centrifugation and 
resuspended in 50 mM Na-phosphate pH 6.8 buffer containing 0.1 mg/ml 
lysozyme and protease inhibitor cocktail (Complete, EDTA-FREE, Roche 
Molecular Biochemicals). Cells were incubated on ice for 10 min and then 
were lysed by sonication for 5 minutes using a Branson Sonifier 250 set to a 
duty cycle of 30% and an output of 3. To remove cell debris, the lysate was 
centrifuged for 15 minutes at 5000 g and then the supernatant mixed with 1 
volume 50% Ammonium Sulfate and left at room temperature for one hour. 
Proteins precipitating at 25% (NH4)2SO4 were removed by centrifugation for 
20 minutes at 6000 g. 
 
2.9.2. Purification on phenyl sepharose column  
 
Phenyl-sepharose column were obtained from GE health care. The protein 
sample (in 25% (NH4)2SO4) was loaded on the column and the flow through 
were collected. Protein elution was performed by decreasing salt concentration 




2.9.3. Protein dialysis  
 
Dialysis of samples from the protein purification was performed using 
Snakeskin Pleated Dialysis tubing (10 kDa MWCO, Pierce), against buffer 
containing 50 mM Na-phosphate and 100 mM NaCl for overnight at 4 ºC. 
2.9.4. Protein concentration  
 
Protein concentration was determined using the BCA protein assay reagents 
from Pierce following manufacturer’s instructions. Bovine serum albumin 
(BSA) was used to prepare standards of known protein concentration. 
 
2.10. Protein gel techniques 
  2.10.1. SDS-polyacrylamide gel electrophoresis (PAGE)  
 
Protein samples were mixed with loading buffer and boiled for 3 minutes prior 
to resolving the samples on SDS-PAGE as described by (Laemmli, 1970). For 
Esp, 10% acrylamide gels were used. A pre-stained protein marker (EZrun) 
was used from Fisher Scientific. After separation of protein samples on SDS-
PAGE, the gel was fixed with 40% methanol and 10% acetic acid for 30 
minutes. Then it was transferred to Coomassie stain (10% acetic acid, 0.025% 
Coomassie G-250) for one hour. Finally, the gel was transferred to destain 






2.11. RNA techniques 
  2.11.1. RNA extraction from Enterococci and Streptococci  
 
Strains were grown to an OD600 of 0.5 in BHI medium. RNA were purified 
using RNA protect bacteria reagent and RNeasy protect bacteria Kits (Qiagen) 
following manufacturer’s instructions. Then RNA were treated with 1 unit of 
DNase I (RQ1 RNase-Free DNase, Promega) per 1 µg of the sample and 
incubated for 30 minutes at 37ºC. Finally, the samples were incubated at 65ºC 
for 10 minutes to inactivate the DNase. 
 
  2.11.2. RT-PCR (Reverse Transcriptase PCR)  
 
SuperScript III One step RT-PCR System (Invitrogen) was used to produce 
cDNA and amplify the resulting product in one step by following the 
manufacturer’s instructions. The results were verified by agarose gel 
electrophoresis as described in section 2.9. Primers used for the one step RT-












Table 2.4 List of primers used in RT-PCR only. 
 
 
RT-PCR Forward primer (5’ to 3’) Reverse primer (5’ to 3’) 
Gallo_2179 TCCCACAACAACATCCTCTGA CGACTACCATCTACACCACCA 
Gallo_2179 GTTTTGTTGGTGAGAGTGCCT TCCCACAACAACATCCTCTGA 
 
 
2.12. Statistical analysis  
 
Differences between conditions were analysed using Student T-test. 
Significance difference was defined as a P-value <0.05, evaluation were 



























Chapter 3: Bioinformatics analysis of the 

















Transport of bacterial polypeptides across the cytoplasmic membrane is 
mediated by a number of distinct processes. Two of these are general secretion 
pathways (GSP) which translocate several proteins. These are the Twin-
arginine Translocation (Tat) pathway, which is able to transport fully folded 
proteins, and the Sec-dependent pathway, which transports unfolded proteins 
across the membrane (Bolhuis, 2002). There are also other systems such as the 
Autotransport (AT) and Two-Partner protein Secretion (TPS), which are 
involved in translocation of specific proteins (Hodak and Jacob-Dubuisson, 
2007). 
Many virulence factors, some of which may be involved in biofilm formation, 
are translocated proteins, and it is therefore of interest to analyse the proteome 
of pathogens for putative secretory proteins. An analysis of enterococcal 
extracellular proteome has already been performed (Meredith, 2013). The goal 
here was therefore to perform a similar analysis on S. gallolyticus. This chapter 
deals with the Sec-dependent pathway only, as streptococci, similar to 
enterococci, do not contain a Tat pathway. 
A simple model for protein secretion through the Sec dependent pathway is 
shown in Figure 3.1. Secretory proteins are synthesized by ribosomes as pre-
proteins with an N terminal signal peptide. This signal peptide is recognized by 
chaperones and the translocase machinery to be translocated to the trans side 
of the membrane. Then at the trans side of the membrane the signal peptide is 
cleaved off by signal peptidases (SPases) and the protein will fold to its active 
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form. This process utilises two energy sources: ATP hydrolysis and the proton 
motive force (PMF; (Schiebel et al., 1991). Translocase components include 
the core units SecY, SecG and SecE, and the ATP-driven motor of the Sec 
pathway, SecA. Most bacteria also contain accessory factors such as SecD and 
SecF, but the latter two appear to be absent in organisms such as enterococci, 














Structural features of signal peptides play an important role in directing 
proteins to different pathways to cross the membrane. Therefore, there are four 
types of signal peptides (SP; Figure 3.2): archetypal (Bacterial signal peptide), 
lipoprotein, Tat and prepillin signal peptides (Paetzel et al., 2002); here we will 
mainly focus only on the archetypal signal peptides. The structure consists of 
three regions: N-, H- and C-regions. The N-terminal region consists of positive 
charged residues which promotes directing the signal peptide into the 
membrane. This is followed by a hydrophobic H-region (7-15 residues) which 
contributes to the formation of an  α-helix that spans the membrane (Heijne, 
1990, Paetzel et al., 2002). This is then followed by a more polar C-region, 
which contains the signal peptidase recognition site sequence, Ala-X-Ala,  at 
position -1 and -3 relative to the cleavage site in the pre-protein (Paetzel et al., 
2000).  Lipoprotein signal peptides have a similar structure, but their signal 
peptidase recognition site has the lipobox residues Leu-(Ala, Ser)-(Gly, Ala)-
Cys at -3 to +1 positions, with the Cys residue being modified with a lipo-











Figure 3.2 Types of bacterial signal peptides. A. Bacterial signal peptide 
(archetypal). B. Tat signal peptide. C. lipoprotein signal peptide. D. 
prepillin signal peptide. Bold letter (except X) represent the conserved 
amino acid residue and X represent non-conserved amino acid residue. 
Black arrows indicate cleavage sites. Taken from Paetzel et al., (2002), see 









Signal peptides are removed during or shortly after translocation by SPases, of 
which there are two different classes: type I and type II signal peptidase. Both 
of their active sites are at the trans side of the membrane (Paetzel et al., 2002). 
SPase type I are essential for bacterial cells. They belong to the serine protease 
class of proteases and are highly efficient in target recognition. SPase type II, 
or prolipoprotein SPase (Lsp), remove the glycoside-modified prolipoprotein 
signal peptides that contain the lipobox with a Cys residue at position +1 
(Tjalsma et al., 1999, Pragai et al., 1997). 
Many bacteria contain only type I SPase, referred to as the prokaryotic (P) 
type. However, some bacteria have a second type, which is the Endoplasmic-
Reticulum (ER)-type SPases (Tjalsma et al., 1998). P-type SPases are found in 
bacteria, mitochondria and chloroplast, whereas ER-Type are conserved in all 
three life domains (van Roosmalen et al., 2004).  The best studied Gram-
positive organism, Bacillus subtilis, has been shown to contain seven type I 
SPase genes. Five of these genes are chromosome encoded (sipS, sipT, sipU, 
sipV and sipW) and two (sipP) are located on plasmids (Tjalsma et al., 1997; 
Tjalsma et al., 1998). Four of the chromosomal genes are related to P-type 
SPase, whereas the SipW is related to ER-type SPase. However, it is not clear 
why such bacteria may have more than one type SPase and it has been 
suggested that presence of multiple types of SPase may be related to substrate 
specificity or that it simply increases the production capacity of pre-protein 
translocation and also may allow cells to adapt to the changing in 
environmental conditions (van Roosmalen et al., 2004). Interestingly, 
enterococci also have multiple SPases, with e.g. both E. faecalis and E. 
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faecium containing three, with one of these being of the ER-type and the two 
others of the P type (Meredith, 2013). Again, the reason why enterococci 
contain multiple type I SPases is unknown. S. bovis appears to contain only 
one P type SPase I, whereas it lacks an ER type SPase (data not shown). This 
is rather surprising as S. bovis is closely related to E. faecalis and E. faecium. 
As mentioned previously into the introduction of this thesis, S. bovis (and in 
particular S. gallolyticus) has been associated with colon cancer, and there are 
several factors involved in the process of adhesion, invasion and colonising of 
host tissues. Therefore, it was interesting to use bioinformatics to analyse the 
secretion proteins in S. gallolyticus. We chose S. gallolyticus ATCC BAA-
2069 for analysis; unfortunately, at the time of analysis, the proteome of                
S. gallolyticus UCN34 (one of the strains used in chapter 6) was not accessible, 
but these two strains are very similar as they are of the same biotype.   
 
3.2. Identification of secretory proteins in S. gallolyticus via 
Sec-pathway  
 
As mentioned before, Sec-dependent secretory proteins contain the signal 
peptide for their translocation. Firstly, we identified secreted proteins with a 
signal peptide using SignalP (V.4.0) software (Petersen et al., 2011). 
Membrane spanning domains of membrane proteins are very similar in signal 
peptides. The N-terminus of such proteins typically contain a positively 
charged N domain followed by a hydrophobic domain. The main difference is 
that they are not cleaved by SPases. However, that is not always clear, and for 
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that reason all SignalP–positive proteins were scanned for multiple membrane 
spanning domains with the server TMHMM (v 2.0; Krogh et al., 2001); all 
proteins with three multiple membrane spanning domains or more were 
removed. The final result is shown in Table 3.1, which represents the putative 
secretory proteins of S. gallolyticus.   
The total number of proteins encoded by S. gallolyticus genome is 2271, and 
90 of those (3.9%) are predicted to be secreted. 4 of those were hypothetical 
proteins, and the remainder have a predicted or known function. As expected, a 
number of transport proteins were observed. These included several ABC 
(ATP-binding cassette) transporters. The ABC transporters utilize ATP to 
translocate various substances across the bacterial membrane. They are of 
particular importance in the transport of various nutrients such as essential 
amino acids, as well as virulence factors (Moussatova et al., 2008). Note that 
there are a number of proteins that, either because of a very short signal 
peptide or based on their function are unlikely to represent genuine secretory 
proteins. These include for instance a DNA topoisomerase (presumably 
cytoplasmic), and YidC, which is a membrane protein involved in the insertion 
of other membrane proteins (Samuelson et al., 2000). All of these have been 
indicated in table 3.1 in italics. Proteins that were expected to be found 
included for instance three collagen-binding proteins (see chapter 6 for more 
details). Other proteins that one would expect to be translocated are 
degradative enzymes such as amylase, pullulanase, autolysin and beta-
lactamase, the latter of which degrades beta-lactam compounds thus providing 
resistance to penicillin and related antibiotics. Also of interest is to note a 
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tannase. This is an enzyme involved in degradation of ester linkages in 
hydrolysable tannins, resulting in the production of gallic acid that 
distinguishes S. gallolyticus from other S. bovis strains. The name gallolyticus 
refers to tannase activity and therefore, decarboxylate gallate which is a 
derived organic acid from tannin degradation, was expected (Rusniok et al., 
2010). 
As mentioned, one of the secreted proteins included was autolysin, an enzyme 
involved in degradation of the cell wall. Apart from autolysin a number of 
other proteins associated with the bacterial cell wall were also seen. Examples 
are penicillin-binding protein (PBP), a peptidoglycan hydrolase and lysozyme. 
These proteins are very important in cell wall turnover, cell division and cell 
wall stress response mechanisms (Popham and Young, 2003, Smith et al., 
2000). Proteins such as lysozyme may also aid in the bacterium’s defense 
mechanisms, whereas PBPs are the target of β-lactam antibiotics; low affinity 
for β –lactams, or mutations that result in low affinity, in PBPs leads to 
resistance to beta-lactam antibiotics such as penicillin.  
Amongst other secreted proteins, a number of competence-associated 
membrane nucleases were seen. These proteins have hydrolase activity and 
contain both metal ion binding and nucleic acid binding domains. Other 
proteins of note include several substrate binding proteins, which have also 
been found in E. faecium (Meredith, 2013), and proteins containing the 
aforementioned LPxTG motif (see chapter 4). These proteins are anchored to 
the cell wall by a specific enzyme, denoted as sortase, which is an extracellular 
protein also listed in Table 3.1.  
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The list also contains a number of lipoproteins. It is possible that the genome 
encodes more lipoproteins, but not all are picked up by the SignalP server as 
the H domain of several lipoproteins is rather short and sometimes more 
difficult to spot.  
Several of the proteins in Table 3.1 may represent virulence factors, some of 
which are likely to be involved in biofilm formation. This includes for instance 
the collagen-binding proteins. Several of the hypothetical proteins may also be 
required for virulence, and it would require a systematic analysis by creating 
knock-outs combined with in vivo studies to test whether that is indeed the 
case. That would be a considerable effort, but initial in vivo studies could be 
performed with simple invertebrate infection models such as the C. elegans 
model as utilised in chapters 4 and 6. 
Finally, one protein in the list, lactocepin, may even have prospects as a 
therapeutic agent. Lactocepin is a secreted protease that is also produced by a 
number of probiotic strains such as lactobacilli. In these organisms is has been 
shown that lactocepin specifically cleaves IP-10, a lymphocyte-recruiting 
chemokine, thereby reducing inflammation in patients with inflammatory 
bowel disease (von Schillde et al., 2012). However, whether this protein from 
S. gallolyticius has similar benefit as its counterpart from Lactobacillus 






3.3. Discussion  
 
Translocation processes are essential for all organisms as they facilitate the 
transport of various proteins across the membrane. In opportunistic pathogens 
several of these proteins are virulence factors such as enzymes, exotoxins and 
biofilm-associated proteins. A detailed analysis of the secreted proteome of 
bacteria can help to understand the possible role and biochemical processes of 
that organism in a particular environment, and in the case of pathogens this 
would include the host. In this chapter a bioinformatics approach was taken to 
conduct an analysis of the extracellular proteome of S. gallolyticus. Various 
secretion mechanisms such as general secretion pathways of the Tat and Sec-
dependent pathways were briefly discussed. Interestingly, S. gallolyticus does 
not possess a Tat pathway. Organisms that do contain this pathway are often 
capable of anaerobic respiration, a process that requires extracellular proteins 
which contain complex cofactors. These cofactors need to be incorporated into 
proteins in the cytoplasm; cofactor-binding requires partial or full folding of a 
protein, which thus necessitates a transport system that can handle folded 
proteins. The Sec system is only capable of transporting unfolded proteins, 
hence the need for the Tat system which is capable of translocation fully folded 
proteins (Robinson and Bolhuis, 2004). In contrast, Gram-positive bacteria 
such as lactococci, streptococci and enterococci lack electron transfer 
complexes, but instead generate energy via fermentative pathways, and it has 
been suggested that their simpler fermentative lifestyle is the reason that these 
organisms do not require a Tat pathway (Yen et al., 2002).  For those reasons, 
this chapter focussed mainly on the Sec-dependent pathway, and in this context 
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a bioinformatics study was provided regarding proteins containing Sec-type 
signal peptides. 
The secreted proteome was analysed using SignalP software to identify 
secreted proteins. These are distinguished by their tripartite nature with a 
positively charged N domain, a hydrophobic H domain, and a polar C domain 
where the signal peptide is processed resulting in release of the mature protein. 
In order to exclude genuine membrane proteins from those that were identified 
by SignalP, another software application, TMHMM, was used to scan for 
multiple membrane passing domains.  
It was observed that 90 out of the 2271 proteins produced by S. gallolyticus 
were predicted to be secreted. The variety of proteins secreted enabled to 
obtain a paint general picture about the biochemical and pathogenic activities 
of S. gallolyticus. It was observed that it was putatively resistant to beta-lactam 
antibiotics due to the presence of the enzyme beta-lactamase. This particular 
strain was not investigated for antibiotic resistance, but of the strains of 
streptococci described in chapter 6, one (S. bovis NCTC 8133) was found to be 
ampicillin resistant (data not shown). The resistance of that strain may thus be 
the results of the production of a beta-lactamase homologous to the one 
identified here. The secreted proteins were also found to include various 
virulence associated proteins such as a number of potential biofilm associated 
proteins, mainly in the form of collagen adhesins. These play an important role 
in biofilm formation, which is a bacterial “lifestyle” that is very important from 
clinical perspective. It has even been suggested that biofilms are involved in 
the majority of human infections (Mohamed et al., 2004). This is very relevant 
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clinically, as biofilms have increased tolerance to antibacterial substances, and 
also horizontal transfer of genetic information such as antibiotic resistance 
frequently occurs in a biofilm environment (Mundy et al., 2000).  
Not surprisingly, a number of proteins involved in the transport of various 
substances across the membrane were observed. Among these, there were a 
number of ABC transporters responsible for amino acid transport. A 
periplasmic component of a Proline/glycine betaine ABC transport system was 
observed. This transporter system helps to protect the bacterial cells from 
osmotic shock (Graham and Wilkinson, 1992). Furthermore, translocated 
proteins with an LPxTG motif were observed, and these thus become anchored 
to the cell wall via a sortase. An efflux protein was also observed; such a 
protein is often associated with the removal of unwanted substances and may 
play an important major role in antibiotic resistance (Morita et al., 2006). 
Bacteria acquire their nutrients from the environment. Often, they are faced 
with the challenge of hydrolysing a complex substrate such as starch before it 
can uptake the released sugars and utilise these for its energy requirements. For 
such purposes, a number of extracellular enzymes are secreted from of the cell. 
These and other enzymes also marks the potential of S. gallolyticus as a 
bacterium of industrial importance, as it produces for instance amylase, 
pullulanase and tannase, all of which are widely used in e.g. the food industry 
(Hii et al., 2012). In addition, also lactocepin was identified, which is believed 
to possess potential therapeutic importance (von Schillde et al., 2012).  
Unexpectedly, some proteins were identified that were not expected. For 
instance, a LytR family transcriptional regulator was observed. Transcriptional 
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regulators are mostly DNA binding proteins and are thus commonly found in 
the cytoplasm. LytR is a regulator that is part of the LytS/R two component 
system and is believed to play a role in biofilm formation in Staphylococcus 
aureus (Sharma-Kuinkel et al., 2009). The presence of this protein amongst the 
secreted proteins is thus surprising, and indicates that false-positive hits are 
conceivable. However, without experimental evidence we cannot exclude that 
LytR is a genuine secretory protein. 
 Overall, the results of the bioinformatics analysis of the secreted proteins of S. 
gallolyticus reveal some interesting information about the virulence and 
biochemical nature of the bacterium. The analysis enables to study the whole 
spectrum of proteins secreted by the bacterium and thus aids in identification 
of novel proteins, which might be of industrial or clinical importance. 
However, the results obtained needs to be validated by wet lab experiments to 
verify that these proteins are indeed produced and secreted to corroborate the 
bioinformatics data. In this respect it should also be noted that expression of 
genes encoding secretory proteins is likely to be regulated, and some genes 
may indeed only be expressed under specific conditions such as nutrient stress. 
For instance, it is conceivable that collagen-binding adhesins are only 
produced during early stages of biofilm formation and/or during an infection 
when collagen is present (see also chapter 6), thus helping the establishment of 
a biofilm. Novel bioinformatics tools have enabled analysis of a vast range of 
cellular products and components across all domains of living organism, and 
the techniques used in this study are important tools in the characterization of 
novel organisms.   
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Predicted function Secreted proteins 
F0VXQ7  DNA topoisomerase  MATTTTTKAPTAVKKSSK/KTT 
F0VYE1  Hypothetical secreted protein  MKRKAVFSLMLLACLVTGILGMNQIKNKDVVA/DDV 
F0VTZ7  Membrane protein insertase YidC  MKRKIKLLGLSSLTLILLAACGRSEVTA/SST 
F0VWB8  Penicillin-binding protein 2B  MSFKKRLSKL/KFA 
F0VTT3  Putative glucan-binding protein D MMRKVLQSILVTFLGLGLLLSAQKVEA/VDA 
F0VX83  Tannase  MPRKKWFFTSSAVLLCSAMLLTACSSSSNSSTSSS/SSQ 
F0VVG2 Alpha/beta hydrolase  MRKIRIRKRRVLLGIIALLFVVSVGA/SFY 
F0VT98 Alpha-amylase MVFRNKEKMKKKLKLGLGSALIFTILGTGTFVQVSVVNA/DTE 
F0VS30 Amino acid ABC transporter, amino acid-binding protein MKIKKIFLGVLALISVLTLAACGSSS/NEN 
F0VXF0 Amino acid ABC transporter, extracellular amino acid-binding protein MKFKKVLVGALALVSTLTLAACSSLSSKKA/TST 
F0VY90 Amino acid ABC transporter, permease protein  MSKKKWIVAGGVVVALVAATVIGRQLTGKTTASA/QSS 
F0VY86 Amino acid ABC transporter, substrate binding protein MKKKVKWIISIIVVALVGLLIFDKVTKNTSEA/KSD 
F0VY50 Amino acid ABC transporter, substrate binding protein  MKIVKRFLAIVSLLVVVLLVGCSTSKS/SSS 
F0VRX4 Autolysin MHLKKNVLRSCLLSPVIIGAFLSSSLVLA/DEN 
F0VU99 Backbone pilus subunit (T6-antigen-like) MKKLKLIFATFFAALFTFTGGKALA/YDI 
F0VXU9 Basic membrane protein A MNKKIVGLGLAAVATLALGACSRSNSSSSSSDSSVKA/AIV 
F0VUN7 Beta-lactamase  MKKLFAVMLIPFFLTSLSVVSTEKTIALT/NEE 
F0VYF9 Capsule biosynthesis protein CapA MFDRIIYKKTTLACLSFLVISLLGSGVYSLA/FEK 
F0VV45 cellobiose-specific IIC component  MSKALIICVAGMSSSLMAQKTTDFF/KNQ 
F0VW36 Collagen adhesin MAKLRKILIALLLLCSSIFSARVAFA/DTV 
F0VSL2 Collagen adhesin  MMRKFIRIFLVLLTTLLTLTGISAKA/EED 









          Secreted proteins 
F0VWQ2 Competence associated membrane nuclease  MKIKTLSAISLTVIPSLILANFCHPFPSSQ/TNS 
F0VWU5 Competence associated membrane nuclease  MAKKSKLSKQTKSLLSLVILLVGIGTGWVTISDS/NDP 
F0VW92 Conserved hypothetical lipoprotein MKKSCKITVILFCSVLLLGACS/KKK 
F0VUI4 Conserved hypothetical secreted protein MKKFATSIIILISLVLVGCTHS/TDS 
F0VWQ5 Cyclomaltodextrin glucanotransferase  MKKRILKFCLGAATLTALMTVPFSQNIVSA/ESY 
F0VTT6 D-alanine extramembranal transfer protein  MLKRLWQILGPVVCAVLIVLLVFICVPTANQ/KHD 
F0VVI6 D-alanyl-D-alanine carboxypeptidase MKKIFAFFAIFLTFLAVGSKVSA/DDD 
F0VXL5 Dextransucrase MKLLGGIMEKKIHYKLHKVKKQWVTIAVTTLALVVGLGAATSTQVVTA/DET 
F0VYE6 Efflux transporter  MPRRSKAKMSKKTKGIIGAAAACFVVAGA/ALL 
F0VX28 Ferrichrome ABC transporter, substrate-binding protein  MKKKLTLLLTAMMVLVMAVFLGACSSSSSSNSTSQSSNA/SEV 
F0VSL1 Fimbrial subunit type 2 MKKLKLILATLLSILFAFTGVKAFA/DES 
F0VV03 Fructan beta-fructosidase MKKEQEKKCVNWFMHKRGKQWIYGCGVLVCGIVLGTVATPVMA/DEA 
F0VXA9 fructose-specific IIB component  MKIVGITSCPAGLAHTPMAAKA/LEK 
F0VXL8 Glucan-binding protein C MFKKSKETFYIRKLTIGVVSVAVAGLLAINNAQVNA/DET 
F0VXL7 Glucosyltransferase-I MEKKVHYKLHKVKKQWVAIAVTSLALVGLGVSVPTQSVSA/DTT 
F0VVJ3 Glycoside hydrolase family 5 MYKVTKNLKKITTALILALVALFAIDSNTEVAYA/ATT 
F0VWL3 Inner spore coat protein H MKNNKSFLLVILLLVVTAGLVLIVGLFTNNDDD/DSS 
F0VTG9 Iron (Fe+3) ABC superfamily ATP binding cassette transporter, binding protein  MKKFFAVLTTFLATFLLVACHNTSSTS/DDT 
F0VWP6 Lactocepin MDKKERFSFRKYKVGLVSVLVGAVFLAAGAGRVSA/DEL 
F0VTS2 LPXTG-motif cell wall anchor domain protein  MKKFFRREYLAQFKAKYKKVIGAIAVIVVFVTTYALILPALTLDSNA/ANQ 
F0VUD6 LPXTG-motif protein cell wall anchor domain protein  MKKQQTLAMVAVTTAVLAGAGTTTFA/DEV 
F0VUL4 LysM and putative peptidoglycan-binding domain-containing protein 3 MQKNTLKSKSKTIKLGVASAAFAAALIAPAVANA/DSY 
F0VSF8 Lysozyme MRRRIKPIVVVVFFALCGLLLVIGKAHS/DSL 








          Secreted proteins 
F0VS37 Maltose/maltodextrin transport system substrate-binding protein MKKNTWKKMVLAGAGLTLAGSVLVACSNSSSNSSS/SSS 
F0VV55 Mannan endo-1,4-beta-mannosidase MKKALVGSLATLTVVAGLASAQGVKA/DEI 
F0VTL0 Membrane protein insertase YidC  MKKKLNRVLFSGLSLSLLFLLTGCVSR/DSS 
F0VV56 Multiple sugar-binding protein  MKKGLLTIGMTALAAVTLVGCSSG/SSD 
F0VW93 N-acetylmuramidase/lysin, putative  MKKSMFGREEQRFGIRKYSVGVASVLIASVLFMGGQTVA/ADD 
F0VSM2 Pectate lyase L MKTTKQVLLVLFSAILMVGMTLAGMSSLKVDA/STT 
F0VVU0 Penicillin-binding protein 1A MITIKKKITRKRK/KTN 
F0VS51 Peptide/nickel transport system substrate-binding protein MEFKSTWKRVGLGVVSLASAALLAACGNSSS/SSS 
F0VS50 Peptide/nickel transport system substrate-binding protein  MEIKNWKRVGLGAVTLLSAAVLAACGNSSS/SSS 
F0VYC2 Peptidoglycan hydrolase  MAKTRKRKVRKKARSHRRQKKVPKWALYGMSLLAVLACVALVIFTYQAQDA/DST 
F0VSN1 Peptidoglycan linked protein MKKVIISHYGLPIVKLMVILVVGILVLGISHTVQA/LTR 
F0VTB3 Peptidyl-prolyl cis-trans isomerase A (Cyclophilin A MKKFWSFGLMVLCLASLSGCESITRA/IRG 
F0VVI7 Periplasmic oligopeptide-binding protein  MLLKSKTWKRIGLGAVTLVSAAVLAACGGSSS/SSS 
F0VT16 Phosphate-binding protein pstS  MKKWKMLMLLAFVGVGVVLTACSKSNS/SES 
F0VXW2 Phosphate-binding protein pstS  MKKMKKLSFLLLITSVSIILSGCASW/IDK 
F0VVT2 Polar amino acid ABC uptake transporter substrate binding protein  MKKRRLLSFGFLFLLTLVLAACSNQSQSSG/KTV 
F0VS32 Polar amino acid transport system substrate-binding protein MKKFFRGFILLIIVGSLSACSSSTGVSQS/SIQ 
F0VSQ7 Polar amino acid transport system substrate-binding protein MKKVLLGLAVLLSASLSVHVEA/ADK 
F0VTP3 Polar amino acid transport system substrate-binding protein  MTLMKKILGVTGVALA/STT 
F0VY99 Proline/glycine betaine ABC transport system,periplasmic component MKNKKVISGALLVVILVAIVGGIWA/WRN 
F0VSA1 Pullulanase PulA and related glycosidases  MKKVSRLSFLEKRQFFGIRKLKVGVASVAIATALFWSASLANSVSA/DQI 
F0VUF5 Putative agglutinin receptor MKNNNVVGRGYFRKSKAYGLVCGIALATAFLGTHVSA/DEV 
F0VSX2 Putative aliphatic sulfonates-binding protein  MKNKKIARKSFIFALLVCWIGVAFYGWKQTQA/DDS 








          Secreted proteins 
F0VXT1 Putative exopolysaccharide biosynthesis protein MRFLKKHAYTLLFSTALLSANVYVLLKTFVIPSAVTKVAA/ETS 
F0VTV6 Putative glucan-binding protein C MKSKHYQALGIGLFSSLVLLTPQVMA/DET 
F0VUC6 Putative glucan-binding protein D MKKSISKGIVLSAVSFLGVFAGSQVVSA/DTD 
F0VSJ8 Putative glutamine transport system substrate-binding protein MKKKLGLAILASLSLILLTLFAGKTTFA/DSV 
F0VTQ2 Putative immunity/modification protein  MKKNVLKSIILLSATVLSMATVSVFA/DDE 
F0VTS1 Putative major pilus subunit  MNNLKKILTPFLTVLALVFVCGAVSA/QTV 
F0VTS9 Putative manganese ABC transporter,substrate-binding liprotein and adhesin  MKKITSLICLLLIICILGACA/TTR 
F0VSM1 Putative pectate lyase related protein  MKKTKRVLSLMFSILLLVAMILTGVSLLKA/DTN 
F0VT44 Putative secreted protein MFMNRKTQLALATATVSGALLFSQVNADA/DTY 
F0VWP9 Putative secreted protein MKKGFYILTIAALSFTLTACS/QNS 
F0VSD5 Putative thioesterase MKKIKKFTLSFLLIIATLIAISGVVLHQKTYQA/SSE 
F0VUD8 Sortase A MKKKIIMLLMV/MIG 
F0VV08 Sugar-binding periplasmic protein MTKLTKIKLW/LSV 
F0VU13 UTP--glucose-1-phosphate uridylyltransferase  MRKVRKAVIPAAGLGTRFLPATKALA/KEM 
F0VV82 YvfO protein MKILKKIFLTTVALIGLAALGTTVTKA/DEF 
F0VWM4 Zinc-binding protein adcA  MKKKFLLLINLVALLFAWQISHIKQVSA/DDK 
F0VTP2 Lipoprotein MKLKKLFGLASVAFASTVLLAACGSSS/SSS 
F0VU52 Lipoprotein MKKKVLSLIVTGFVATILTGCGASQV/ATS 
F0VUG8 Putative lipoprotein  MKKKLLATLLAVMSVFLLVGCSSK/DDL 
F0VWH8 Putative serine rich lipoprotein  MKKTVTYLALAATSVLFLTACSNNN/QES 
*Signal peptide positive charged residues are indicated in bold letter, the H-domain is indicated in grey shading, the residues -1 to -3 positions relatively to 












Chapter 4: Biofilm formation in Enterococci 
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4.1. Introduction  
 
The ability to form biofilms is an important virulence trait that has been 
reported for enterococci. A biofilm is a sessile community of bacterial cells 
surrounded by extrapolymeric substance (EPS) which provides a strong 
framework and protection, and facilitates cell to cell communication. EPS is 
composed of different materials including proteins, nucleic acids and 
polysaccharides (Molobela et al., 2010) . 
Enterococci are commonly found as intestinal microorganisms which also have 
been reported to cause infections such as endocarditis(Singh et al., 2010). 
Adhesion to host extracellular matrix components (ECM) is the first step for 
pathogens to mediate infection, and important in promoting enterococci to 
colonize host vascular tissues are interactions between enterococcal surface 
proteins and host proteins such as Collagen and laminin. In fact, many studies 
have reported surface proteins with characteristics similar to immunoglobulin-
like fold which are named MSCRAMMs (Microbial Surface Components 
Recognizing Adhesive Matrix Molecules; (Nallapareddy and Murray, 2006). 
Indeed, many well-characterized surface proteins in Gram-positive bacteria 
(such as streptococci, staphylococci and enterococci) are MSCRAMMS 
(Walsh et al., 2008, Sillanpää et al., 2009). These proteins share several 
characteristics including an N-terminal signal peptide sequence followed by an 
A-domain which consist of one or multiple subdomains, each of which adopt a 
IgG-like fold (immunoglobulin G-like). Following the A-domain is a series of 
repeated sequences that is referred to as the B-domain. The C-terminal has the 
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LPXTG like motif which required for cell wall anchoring (Hendrickx et al., 
2009, Liu et al., 2007). 
Genome sequencing of E. faecalis V583 and E. faecalis TX0016 revealed the 
presence of 17 and 15 MSCRAMMs, respectively. Three enterococcal 
MSCRAMMs have been studied in detail. Ace (adhesion of collagen from E. 
faecalis) was the first protein described among Enterococcal for interacting 
with collagen type I and IV, laminin and dentin. Acm (adhesion of collagen 
from E. faecium) interacts with collagen type I and lesser extent with type IV. 
Finally, Scm (second adhesion of collagen of E. faecium) binds to collagen 
type V and fibrinogen (Sava et al., 2010). 
Furthermore, other virulence factors reported to have important roles in biofilm 
development and pathogenesis of E. faecalis, including cell wall adhesion 
proteins and secreted proteins (see section 4.2; (Pires-Boucas et al., 2010). 
The aim of this chapter is to characterise three E. faecalis strains that were 
isolated from biliary stents. However, there are no genome sequences available 
for these strains. So, these are mainly preliminary studies aimed at testing a 
number of factors, including the presence of virulence factors, pathogenicity 







 4.2. Cell surface proteins and other virulence factors in E. faecalis  
 
As mentioned before into the introduction of this thesis, that several virulence 
factors in Enterococci have been described, for instance, aggregation substance 
(AS), Enterococcal surface protein (Esp), E. faecalis endocarditis associated 
antigen A(EfaA), adhesion of collagen of E. faecalis (Ace), gelatinase (GelE) 
and the toxin Cytolysin (see chapter1 table 1.2). 
AS is an E. faecalis surface-anchored protein which facilitates transfer of 
plasmids between cells by allowing the adherence of the donor bacterium cells 
to recipient cells (Dunny, 1990). In addition, aggregate substances mediate 
adherence into host tissues and, enhance biofilm formation by cell aggregation 
(Kreft et al., 1992, Chow et al., 1993).    
Enterococcal surface protein (Esp) is a cell wall protein. Studies observed an 
association of Esp in the initial attachment and biofilm formation of E. faecalis 
on abiotic surfaces (Toledo-Arana et al., 2001).. More details on Esp are in 
chapter 5 of this thesis. 
E. faecalis endocarditis antigen A (EfaA) amino acid sequence analysis 
showed 55% to 60% similarity to a group of streptococcal proteins, (FimA 
from Streptococcus parasanguis, SsaB from Streptococcus sanguis, ScaA from 
Streptococcus gordonii, and PsaA from Streptococcus pneumonia), which have 
been shown to be involved in adhesion in endocarditis (Lowe et al., 1995).  
As mentioned early into the introduction of this chapter, that colonization of 
human tissue is occur via interaction between ECM protein ligands and the 
pathogen MSCRAMMs cell wall anchored proteins (Hendrickx et al., 2009). 
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 In endocarditis, the disruption of the valvular endothelium leads to exposes of 
the underlying tissue which by deposition of the host proteins including ECM 
material such as, collagen and fibrin may become colonized by circulating 
bacteria (Singh et al., 2010). Previous studies have shown that Ace mediates E. 
faecalis attachment to immobilized collagen. The mechanism by which Ace 
could bind to collagen was named The Collagen Hug Mechanism (Hendrickx 
et al., 2009). 
E. faecalis Ace shares sequence similarity with S. aureus MSCRAMM (Can). 
Characteristics of these proteins including an N-terminal signal peptide 
followed by A-domain then B-domain and C-terminal. Based on the studies on 
S. aureus Cna, it was shown that the collagen binding activity is located in the 
A-domain. However, A-domain consists of two subdomains, N1 and N2, 
which are predicted to adopt an open configuration to allow the collagen triple 
helix to “dock”. As a result the MSCRAMM subsequently hugs around the 
collagen to “lock” between the two subdomains. Finally the structure stabilized 
by insertion of C-terminal “latch” extension of N2 in to the trench cleft of N1 
subdomain (See figure 4.1; Hendrickx et al., 2009, Liu et al., 2007). 
 




E. faecalis Ace has reported to contribute in pathogenicity in a rat model 
endocarditis(Singh et al., 2010). Also, the same study confirmed inhibition of 
E. faecalis collagen adherence by using active and passive immunization based 
on the collagen binding domain of Ace. Thus, this study did not only indicate 
the importance role of this protein in endocarditis, but also showed promising 
therapeutic strategies against E. faecalis endocarditis. 
Other virulence factors including secreted proteins been involved in 
pathogenicity of E. faecalis are gelatinase and serine protease which encoded 
by gelE and sprE, respectively, with both genes located on the same operon. 
Both secreted proteases are regulated by fsr, a regulatory two component 
system (see chapter 1; (Gaspar et al., 2009). 
GelE is a secreted zinc-metalloprotease gelatinase. Its gene, gelE is an operon 
with the serine protease sprE with the latter located immediately downstream 
from gelE (Gaspar et al., 2009). Gelatinase is able to degrade several substrates 
such as casein, gelatin, fibrin and other immune peptides (Thurlow et al., 
2010). Also, GelE has been shown to have a role in development of biofilms of 
E. faecalis  (Hancock and Perego, 2004). However, there are a number of 
theories of how GelE promotes biofilm formation, one being that GelE 
increasing cell surface hydrophobicity by cleaving cell surface proteins at 
hydrophobic residues and therefore, enhanced cell attachment to the surface 
(Carniol and Gilmore, 2004). Another theory on the role of GelE was recently 
also proposed, (Thomas et al., 2008). In this, GelE either activates its own 
autolysin, or activates the autolysin localized on a sibling cell, resulted in 
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allolysis or fratricide “sibling-killing-sibling”. Both mechanisms result in cell 
lysis and subsequence release of extracellular DNA (eDNA) which is 
important in the development of biofilm formation.  
Several studies have reported a reduction in biofilm formation of E. faecalis 
mutant lacking gelE (Thomas et al., 2008, Mohamed et al., 2004). Also, 
contribution of GelE in pathogenicity against  C. elegans model has been 
demonstrated (Sifri et al., 2002). 
 
Figure 4.2 E. faecalis GelE activation autolysis model (Fratricide model). 
A, producer cell, B, sibling cell, GelE and SprE both illustrated by the 
black and the white spots, respectively. Active or inactive form of 





Cytolysin or hemolysin are other secreted proteins which are related to S. 
pyogens streptolysin(Cox et al., 2005). Production of these proteins involves 
several genes that are encoded either on a plasmid or on the chromosome 
(Haas et al., 2002).  
The Enterococcal hemolysin has been associated with lethality in endocarditis. 
A study done using a rabbit model with endocarditis was intravenously 
injected with an E. faecalis strain with/without defective in expression 
cytolysin. Vegetation on the heart valves associated with lethality were 
observed in 55% of animals injected with wild-type strains, whereas this was 
only 15% with strain defective in cytolysin expression (Cox et al., 2005). 
Also, another study observed that E. faecalis cytolysin enhanced C. elegans 
nematode killing (Garsin et al., 2001). Beside that other studies showed the 
contribution of cytolysin in destroying and damaging of human erythrocytes 
and intestinal and retinal tissues (Jett et al., 1992, Haas et al., 2002). 
 
4.3. Analysis of virulence factors in E. faecalis BS11297, 
BS12297, and BS385.  
 
Three clinical isolates of E. faecalis, all obtained from biliary stents, were 
kindly provided by Dr Bastiaan Krom (University of Groningen). These strains 
have not been characterized extensively, and our first goal was to identify the 
presence or absence of a number of virulence factors that were described 
above. To determine the presence or absence of these virulence factors, PCR 
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reactions were performed, using E. faecalis V583 as a positive control. The 
primers used are listed in chapter 2 and the results are shown in Table 4.1.  
 
 
Table 4.1 Detection of some virulence factors in E. faecalis strains by 
PCR. 
Strain        gelE          esp         efa         ace        cylB 
BS11297 + + + - + 
BS12297 - + + + - 
BS385 - - + - + 
Absence (-) or presence (+) of genes encoding virulence factors as determined by 
PCR. gelatinase GelE, Enterococcal Surface Protein Esp, E. faecalis endocarditis 
Associated Antigen A EfaA, Adhesion of Collagen of E. faecalis Ace, and Cytolysin 
CylB. 
 
Even though all three strains were isolated from biliary stents, they differed 
considerably in the virulence factors present. Efa was the only factor common 
to all three, but other factors were only found in two (Esp, CylB) or one (GelE, 
Ace) of the strains. The presence of GelE was also verified by growing the 
strains on TSB medium containing 0.5% milk powder. Only E. faecalis 
BS11297 formed a large clearing zone around the colony, indicating 
production of a secreted protease and confirming that only this isolate produces 






Figure 4.3 E. faecalis BS11297, BS12297 and BS385 grown on 0.5% milk 
agar plates. The size of the clearing zone is proportional to the level of 
extracellular proteolytic activity. 
 
4.4. Effects of sodium azide 
    4.4.1. Effects of sodium azide on enterococcal biofilm formation  
 
Previous studies have shown that sodium azide acts as an inhibitor for Sec-
dependent translocation by inhibition of the ATPase SecA(Miller et al., 2002). 
As most surface proteins in enterococci are predicted to be Sec dependent, it 
was anticipated that sodium azide could be used for preliminary studies into 
the importance of the Sec system in biofilm formation in Enterococcus faecalis 
strains by testing the effects of  sodium azide (Pires-Boucas et al., 2010). 
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To get a first impression of biofilm formation of the E. faecalis strains, 
biofilms of the three clinical isolates were grown in 96-well plates. As shown 
in Figure 4.4 there is a great variation in the amount of biofilm formed between 
the strains, with E. faecalis BS12297 being able to form good biofilms, E. 
faecalis BS11297 forming very poor biofilms, and E. faecalis BS385 in 
between the two. This confirms earlier reports by Van Merode et al,. (2006) 
(van Merode et al., 2006b). To analyze the effects on perturbation of the Sec 
pathway, we first tested effects of different concentrations of sodium azide by 
analyzing its effects on the growth of one of the three strains. Enterococci are 
known to be very tolerant to sodium azide, and the minimal inhibitory 
concentration (MIC) for sodium azide was determined to be 12,800 µg/ml (for 
all three strains). This is very high compared to other bacteria; for instance, the 
MIC for S. aureus is 186 µg/ml and for E. coli is 34 µg/ml (Zhou et al., 2010). 
Growth curve of one of the strains is shown in Figure 4.4. Growth was slowed 
with increasing concentrations of azide and a concentration of 200 µg/ml of 
sodium azide was chosen for further analysis. Surprisingly, only in one of the 
strains (BS11297) was there a significant effect on biofilm formation (Figure 
4.5). In the other two strains small differences were noted, but these were 









Figure 4.5 Biofilm formations in E. faecalis strains. BS12297 only showed 
a significant reduction with 200 µg/ml azide, the error bars represent the 











































4.4.2. Effects of sodium azide on hydrophobicity of Enterococci 
 
Hydrophobicity of the cell surface is an important determinant of biofilm 
formation. This is easily measured by determining the distribution of cells 
between water and hexadecane layers. Figure 4.6 shows that hydrophobicity 
correlates with biofilm formation, with E. faecalis BS12297 being the most 
hydrophobic, BS11297 the least, and BS385 in between. In the case of 
BS12297 and BS385 hydrophobicity was affected, which could suggest that 
sodium azide affects the composition of the cell wall and thereby, at least in 
part explains the reduction in biofilm formation in these strains. In BS11297, 
which is a poor biofilm former, azide did not have an effect on hydrophobicity. 
  
 
Figure 4.6 % of Cell surface hydrophobicity of E. faecalis (BS12297, 
BS385, and BS11297). Addition of 200 µg/ml sodium azide reduced the 
hydrophobicity in E. faecalis BS12297 and BS385 more than BS11297. 























To test whether sodium azide indeed affects protein secretion in E. faecalis, the 
effects of this were investigated on the production of extracellular proteases in 
E. faecalis BS11297. Protease activity was determined with the substrate 
azocasein, in which the hydrolysis of casein leads to release of an azo dye that 
can be detected at 440 nm.  Figure 4.6 shows that BS12297 protease 
production was not effected in the presence of sodium azide, corroborating the 
results found on hydrophobicity. BS11297 has significantly increased 
extracellular protease activity compared to BS12297 (figure 4.3 above and 
figure 4.7). This is very likely due to the presence of GelE in BS11297, 
whereas this protease is absent in BS12297 (van Merode et al., 2006b). 
Surprisingly, GelE was produced at a much higher level in BS11297 in the 
presence of azide. The reasons for this are unclear, but it could be speculated 
that azide causes a stress response that result in overexpression of proteases 
such as GelE. However, earlier findings showed that the presence of GelE 
stimulates biofilm formation(Thomas et al., 2008). This was not the case here 
as results showed that sodium azide increased GelE production in BS11297 (in 
which GelE is the major protease) while biofilm formation was somewhat 
reduced. The question is thus whether this is a direct effect of the amounts of 
GelE produced or whether there are other reasons for the effects of sodium 






Figure 4.7 Protease activity produced by E. faecalis (BS11297 and 
BS12297). Presence of 200 µg/ml sodium azide decreased the protease 
activity in BS12297, whereas in BS11297 azide significantly (p≤ 0.00075) 
increased the protease activity. The error bars represent the mean ± 
standard error (n=6). 
 
 
4.5. Presence of eDNA in the matrix of E. faecalis biofilms  
 
Extracellular DNA may be one of the components of EPS, but its presence 
needs to be tested as it is not found in all strains. It was thus important to verify 
this by treating the biofilm of E. faecalis strains with DNase as reported 


















100 µl DNaseI was diluted in THB+0.25% glucose medium to a final 
concentration of 100KU, which was then added to 100 µl of an overnight 
culture and the Crystal violet assay were carried out as usual.  As shown in 
figure 4.8, E. faecalis biofilms of all strains tested decreased when treated with 
DNaseI, although the effects in BS11297, BS385 and ATCC19433 were 
statistically not significant. However, in the strongest biofilm former, E. 
faecalis BS12297, the effect of DNase was significant (p=0.012) indicating 
that at least in this strain DNA forms a part of the EPS. 
 
Figure 4.8 Biofilm formation in E. faecalis strains treated with DNaseI. 
BS12297 only showed a significant reduction with 100KU DNaseI, The 























4.6. Biofilm formation of E. faecalis in the presence of collagen  
 
As mentioned earlier in this chapter, many infections biofilms are formed on 
tissues in the body. A number of cell surface proteins are involved in this 
process, and one important group of such proteins are the aforementioned 
MSCRAMMs. Indeed, MSCRAMMs of streptococci and staphylococci have 
been identified to have a main role in adherence and colonization in vivo 
(Nallapareddy and Murray, 2006). We have shown that collagen-binding 
proteins are important in biofilm formation in a number of streptococcal strains 
(Sillanpää et al., 2009, Walsh et al., 2008; see chapter 6 in this thesis). Nothing 
is known about the capabilities of the E. faecalis strains described before with 
regards to adherence to collagen, and it was therefore of interest to test this.  
In this experiment, biofilms were grown in 96-well plates pre-coated with 
collagen I, collagen IV, or in plates without coating. As shown in Figure 4.9 
the presence of collagen did not significantly enhance biofilm in E. faecalis 
BS11297 and BS385. However, E. faecalis BS12297 formed more biofilm in 





Figure 4.9 Biofilm formed by E. faecalis strains on collagen surface. 
Biofilm formation was tested in wells pre-coated with collagen I, IV and 
no collagen. BS12297 only showed a significant increase in the presence of 
collagen IV. CI and CIV= collagen type one and four, respectively. The 
error bars represent the mean ± standard error (n=12, *p= 0.008). 
 
4.6. Cloning of gelE  
 
To analyze the effect of the protease GelE on enterococcal biofilm formation 
and pathogenicity, gelE was cloned in an expression vector and transformed 
into E. faecalis strain lacking GelE. The purpose here was to (a) analyse the 
effects of overproduction of GelE on biofilm formation, and (b) test whether 
these effects could also be observed in strains normally not containing GelE. 
The latter could provide a means to test the need for other partners in the 
effects of GelE.  
A 1573-bp long DNA fragment of gelE was amplified from genomic DNA of 
E. faecalis BS11297 using the KAPA2G robust PCR kit. The PCR product was 






















with XbaI and SacI, followed by electroporation in to E. coli competent cells 
with selection on LB medium with 60 µg/ml spectinomycin and 15 µg/ml 
chloramphenicol. Then plasmid DNA was purified using Nucleospin plasmid 
kit followed by electroporated in to E. faecalis BS385. Plasmids containing the 
gelE gene were obtained. The construct as intended is shown in Figure 4.10. 
However, upon sequencing it was noted that none of the constructs obtained 
contained a complete gelE gene and there were rearrangements within the 
plasmid, suggesting that cloning of a protease is deleterious to E. coli cells. 
Similar problems with cloning of foreign proteases has been observed before 











Figure 4.10 Vector pAT-gelE. gelE were ligated into the SacI, XbaI site of 
pAT79. The resulting construct formed pAT-gelE. Spc and cat encode 





4.7. Pathogenicity of enterococci in a nematode infection model (C. 
elegans)  
 
C. elegans is a soil nematode feed on E. coli and it has been fully genomic 
sequenced and studied. Moreover, for its small size, easy cultured and short 
life span, make C. elegans attractive resources for many researchers (Sifri et 
al., 2005, Mellies et al., 2006). Recent studies suggested that C. elegans can be 
used as in vivo infection model to detect pathogenicity for various 
microorganisms such as Pseudomonas aeruginosa, E. coli and Staphylococcus 
aureus (Lavigne et al., 2008). Bacterial pathogens kill nematodes either by 
“slow killing”, by colonising and infecting, for instance, the gut of nematodes, 
or by “fast killing” through the production of toxins (Mellies et al., 2006). 
The result in figure 4.11 shows the % of survival C. elegans after been infected 
with E. faecalis strains. E. coli HB101 used as non-pathogenic control strain. 
The lifespan of the nematodes was considerable shorter when infected with any 
of the E. faecalis strains, but in particular E. faecalis BS11297 and BS385 





Figure 4.11 Survival of C. elegans after infected with E. faecalis isolates. E. 
coli HB101 is a non pathogenic control. The error bars represent the mean 
± standard error. (n=9) 
 
 
4.8. Discussion  
 
Biofilm assays were performed on different E. faecalis strains, showing 
variation in biofilm formation between the strains. Several factors are involved 
in this process. E. faecalis BS11297 and BS12297 both contain the 
enterococcal surface protein Esp, but the latter formed significantly more 
biofilm in all the tests. A previous study on the cell culture surface charge 
heterogenicity reported that cultures of E. faecalis BS11297 are much more 
homogenous, i.e. showing little variation between cells, as compared to 
BS12297. It has been suggested that surface charge heterogeneity stimulates 
adhesion to the surfaces, explaining why the latter is better at forming biofilms 
(van Merode et al., 2006a). E. faecalis BS385 is also heterogeneous but lacks 























explaining why BS385 was not able to form biofilms as good as BS12297 (van 
Merode et al., 2006b).  
Furthermore, previous studies demonstrated the role of both extracellular 
proteases (GelE and SprE) in biofilm formation by providing eDNA resulted of 
activation of autolysin (Thomas et al., 2008). This was not observed here with 
isolate BS11297; this strain produces GelE, but it nevertheless formed very 
poor biofilms. Furthermore, DNaseI treatment of this strain showed only a 
marginal reduction in biofilm formation of E. faecalis, indicating that DNA is 
not a major component of the EPS in this isolate. This indicates that it is not 
easy to predict how well a strain can form biofilms by simply looking at the 
presence or absence of factors such as GelE or Esp, and that biofilm formation 
is a complex process depending on several factors. Thus, to study function of 
cell surface or extracellular proteins in biofilm formation it is clearly important 
to only compare strains with the same parental background. This explains other 
contradictory studies, with some showing that biofilm formation is 
independent from Esp and others showing that Esp is important (Toledo-Arana 
et al., 2001). One study showed that E. faecalis with mutations in the fsr-locus 
(which is involved in the regulation of e.g. gelE ) or gelE resulted in poor 
biofilm formation. In the same study fsr-only mutants formed wild-type 
biofilm level by addition of purified GelE, suggesting that GelE alone could 
enhanced biofilm formation (Hancock and Perego, 2004). Effects of 
overproduction of GelE on biofilm formation have not been studied. An initial 
aim of our study was to investigate this, but we were unable to clone an intact 
gelE gene, possibly due to toxic effects of a protease in E. coli.  
81 
 
This part of the study was therefore not investigated further. What we did show 
here that hydrophobicity appears to be a better predictor of biofilm formation, 
which is important in bacterial adhesion on the substratum; the more 
hydrophobic the strain, the more biofilm it can form (Bruinsma et al., 2001). 
Sodium azide (NaN3) is a compound which used in laboratory and industrial 
applications for example it used as a preservative reagent (Marino et al., 2007). 
It is also a potent inhibitor of SecA, which is the central motor in Sec-
dependent protein translocation. We have examined the effect of NaN3 on E. 
faecalis strains in their biofilm formation, hydrophobicity and protease 
secretion. Our results suggested that the NaN3 has reduced both biofilm 
formation and hydrophobicity in all strains. However, addition of NaN3 did not 
have much effect on the protease activity in E. faecalis BS12297. In contrast, 
azide significantly increases protease (probably GelE) production in BS11297. 
The latter effect could be due to the stress of growing in the presence of azide. 
Indeed, a recent study reported that environmental stresses is often coupled to 
expression of virulence genes, which may be a survival strategy under adverse 
conditions (Lenz et al., 2010). Note however that it is not clear whether the 
stimulation of expression of gelE by azide is strain specific or more widely 
applicable, as other strains containing GelE have not been tested.  
Enterococci have also been reported to have a putative collagen binding 
proteins, Ace and Acm for E. faecalis and E. faecium, respectively (Rich et al., 
1999). Ace is a homologue of Cna from S. aureus (Rich et al., 1999, Garsin et 
al., 2001), which belongs to the family of MSCRAMMS. We have tested the 
biofilm formation of E. faecalis strains on collagen I and IV, and our results 
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showed that biofilm formation of neither BS11297 nor BS385 was influenced 
by the presence of collagen. Interestingly, BS12297 did form better biofilms on 
collagen (in particular collagen IV), and that was also the only strain, as 
confirmed by PCR, containing Ace.  
Interestingly, our data confirmed E. faecalis virulence against C. elegans 
nematodes. The most pathogenic strain was BS11297, followed by BS385 and 
BS12297. This was in reverse order of the capability of biofilm formation of 
these strains, indicating that in the conditions tested biofilm formation per se is 
not a factor in the level of pathogencity. However, the three strains differed 
considerable in virulence factors present and, again, a straightforward 
comparison is therefore difficult to make.  Nevertheless, the most pathogenic 
strain (BS11297) contained both cytolysin CylB and protease GelE, strain 
BS385 contained only CylB, and the least pathogenic strain (BS12297) lacked 
both of these proteins. Thus, it may be that in particular CylB and GelE play an 
important role in the pathogenicity in nematodes. This would need to be 














Chapter5: Role of Enterococcal Surface 


















As mentioned previously into the introduction of this thesis that sec-dependant 
pathway consist of many components react together to transport different 
proteins which contain a signal peptide across the cell membrane (Mori and 
Ito, 2001). 
Many of virulence factors mentioned in this thesis are transported through sec 
machinery system for example, Esp, collagen binding proteins and AS. These 
proteins characterized by C-terminus LPxTG motif (x indicates for any amino 
acid) and therefore, attached to the cell wall by sortase (Hendrickx et al., 
2009). This enzyme cleaves between the threonine and glysine residues in this 
motif to allow the proteins covalently immobilized the cell wall peptidoglycan 
(Hendrickx et al., 2009).   
Enterococcal surface proteins (ESP) are large cell-wall protein with molecular 
mass approximately 202KDa, found both in E. faecalis and E. faecium . The 
proteins in both strains showed similar sequence identity of around 90% 
(Leavis et al., 2004). 
The structure of Esp (figure 5.1) reveals some key features including a signal 
peptide, N-terminal domain, A,B and C repeats domains which contains cell 
wall anchoring motif and here with Enterococci the motif has[Y/F]PKTG 
sequence which the Leucine in position 1 has been replaced with either 
Tyrosine or Phenylalanine (Hendrickx et al., 2009). In spite the variation in the 
motif residue, Esp has been detected on the cell wall surface by experiments 






Figure 5.1 E. faecium E1162 Esp structure. The signal peptide motif 
YSIRK represent in purple, then N-terminal domain, A, B&C repeats 




It has been reported that N-terminal a lone is sufficient to mediate biofilm 
formation in E. faecalis (Tendolkar et al., 2005). 
Esp shows similarity to other biofilm associated proteins in other organisms, 
which include BapA from Salmonella enteritidis, Lap from Pseudomonas 
fluorescens and S. aureus from Bap (Latasa et al., 2006, Lasa and Penades, 
2006). For instance, the N-terminal domain of E. faecalis Esp has 33% identity 
with S. aureus Bap (Biofilm Associated Protein), and also the C-repeat region 
of these proteins showed similar levels of identity(Toledo-Arana et al., 2001). 
This C-repeats region has been shown similarity to repeats in the Rib and C 
alpha proteins in group B streptococcus (GBS) (Shankar et al., 1999). 
However, these proteins have different functions than the aforementioned 
proteins; both Rib and C alpha are surface expressed antigens, which have 
been shown to be involved in resistance against antibody-mediated immunity 






Figure 5.2 Structural similarities between Bap and Esp. Signal peptide 
(SP), membrane anchor (MA). Taken from Toledo-Arana et al., (2001). 
 
 
Studies on Esp have shown variation in the number of A and C repeats 
between isolates as a result of homologous recombination. Strikingly, although 
(as mentioned above) the repeat domains are dispensable for biofilm 
formation, none of Esp positive isolates showed a complete A or/and C repeats 
loss, suggesting that they may have a role in maintaining Esp stability(Shankar 
et al., 1999). Also, variation in the repeats region showed no effect on isolates 
to form biofilm (Toledo-Arana et al., 2001). Furthermore, it has been observed 
in C alpha proteins that the shuffling of repeats is a technique for possible 
immune evasion (Madoff et al., 1996, Madoff et al., 1991). 
Several studies have, as outlined above, shown the involvement of Esp in 
biofilm formation. However, all of these are based upon genetic studies, but 
the true biological function of Esp is not known. The main aim of the work in 
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this chapter was therefore to initiate biochemical studies on the Esp protein. As 
shown here we developed a biochemical assay to test the activity of the N-
domain of Esp that may be used to further elucidate the function of Esp.  
5.2. Esp expression analysis using SDS-PAGE 
 
Firstly a fragment of the esp gene encoding the N-domain was cloned in the E. 
coli expression vector pET28a vector. The N-domain was expressed without its 
signal peptide (denoted EspN), but with a C-terminal 6His-tag to enable 
purification. The protein was expressed in E. coli BL21 (DE3) on incubation 
with 1 mM IPTG at 37˚C (see materials and methods chapter). 
Initial trials to purify the protein on metal chelating columns were not 
successful as the protein failed to bind to columns loaded with either Ni2+ or 
Co2+, indicating that either the His-tag is hidden within the protein, or perhaps 
cleaved off. Therefore an alternative purification strategy was developed (see 
materials and methods chapter). Firstly, ammonium sulphate was added to cell 
lysates to 25%, a concentration at which Esp does not precipitate. Then, lysate 
was loaded on a phenyl-sepharose column (bed volume ~ 5 mL), and proteins 
were eluted step-wise by decreasing ammonium sulphate concentration and the 
resulting fractions was resolved on SDS PAGE and visualized using coomassie 
stain. As can be observed in Figure 5.3, the Esp was not completely pure as 
some background bands were still visible. Also, it was decided to test the effect 






Figure 5.3 Purified fraction of Esp on SDS PAGE gel. .M, proteins 
marker, FT, flow through and the percentage represent the ammonium 
sulphate concentration. 
 




5.3. Effect of purified EspN on biofilm formation in E. 
faecium 
 
To test the effect of addition of purified EspN on biofilm formation, it was 
decided to test that on E. faecium E1162, E1162∆esp and E. faecium TX1330, 
the latter two of which lacking esp. Firstly, purified EspN was dialysed against 
buffer (containing 50 mM Na-phosphate and 100 mM NaCl) to remove 
ammonium sulphate. Then, a biofilm assay was carried out using the standard 
96-well microtitre plate biofilm assay, but here 100 µl of a diluted overnight 
culture was added to 100 µl of purified EspN (200 µg/ml), after which cultures 
were incubated for 24 hours, followed by washing and crystal violet staining as 
usual. As a negative control, the Esp protein was treated with trypsin (10 µg/ml 
for 1hour at 37˚C), followed by inactivation of the trypsin with trypsin 
inhibitor. 
Results in figure 5.5(a) shows that addition of EspN has significantly increased 
biofilm formation in both E. faecium E1162∆esp and TX1330, both of which 
lack esp. Also, E1162 showed an increased in biofilm formation, but the 
difference observed was statistically not significant. In E. faecium E1162∆esp, 
addition of trypsin-digested EspN did not alter biofilm formation significantly, 
indicating that the protein was inactivated by trypsin. In the wild-type E1162, 
the biofilm actually even reduced in the presence of trypsin-digested EspN, 
either suggesting that trypsin-treated EspN interfered with biofilm formation, 
or that the trypsin was not fully deactivated and that trypsin itself interfered 
with biofilm formation. Confusingly, in the case of TX1330 biofilm formation 
was still increased compared to the control (albeit not as high as with full 
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length Esp), indicating that the trypsin-treated EspN has in fact still some 
activity. Strikingly, when analyzing the trypsin-treated EspN by SDS-PAGE it 
was observed that about half of the amount of protein still appeared largely 
intact, while the other half was only of a slightly lower molecular weight 
(Figure 5.4). Also, it has been decided to look at the effect of pre-heated EspN 
on E1162∆esp biofilm formation and results in figure 5.5(b) shows that pre-
heated EspN for 10 minutes at 80˚C or 90˚C also were significantly reduced 
compared to untreated EspN, albeit that biofilm formation was slightly better 
than after trypsin treatment, indicating that heating does not denature all of the 
protein. The difference was however statistically not significant. 
To analyse in more detail the nature of the trypsin-digested EspN, the samples 
were analysed by Fourier-Transform Icon Cyclotron Resonance (FTICR) 
spectrometry (the mass spec facility at the University of Edinburgh) to 
determine the exact size of EspN and trypsin-treated EspN. The size of EspN 
was determined to be 82510 Da. This was in fact larger than anticipated, and 
the actual size of EspN (including the 6His tag) is 80210 Da. The size 
determined was thus 2.3 KDa larger than expected. Unfortunately, the size of 
the trypsin-treated sample could not be determined. It should be noted that the 
size of the proteins is fairly large and it is on the border of what FTICR mass 







Figure 5.5a Effect of purified EspN and pre-digested EspN with trypsin on 
E. faecium strains.   E. faecium strains, E1162 (+esp), E1162∆esp and 
TX1330 both lacking esp. the error bars represent the mean ± standard 
error, (n=6, *p<0.05**p<0.03). 
 
 
Figure 5.5b Effect of pre-heated purified EspN on E. faecium E1162∆esp. 














































5.4. Effect of purified EspN on hydrophobicity of E. faecium 
 
As showed previously in chapter 4 with E. faecalis that hydrophobicity is an 
important factor biofilm formation, and strains lacking Esp are significantly 
less hydrophobic. It was therefore anticipated that addition of EspN would 
increase hydrophobicity of the strains, and this was measured. Surprisingly, as 
shown in Figure 5.6, addition of Esp did not alter hydrophobicity significantly 



































5.5. Crystallisation of EspN 
 
Initial attempts were made to crystallise the purified EspN protein. Four 
different screens (from Molecular Dimensions) were tested (at 50 nL scale) 
with the help of Dr Susan Crennell (Dept of Biology and Biochemistry, 
University of Bath). This involved 96 different buffers in each, with 3 different 
ratios of buffer:protein (1:2, 1:1 and 2:1), thus a total of 288 conditions per 
plate. Unfortunately, only in one condition (in the Morpheus screen), small 
crystals were obtained, and that appeared not to be reproducible when scaled 
up to a larger volume. Due to time constraints this was not pursued any further, 
but future studies on this should focus on, firstly, a higher level of purity of the 
protein and, secondly, a higher concentration of protein. In the condition tested 
the concentration of EspN was around 5 mg/mL, but a concentration of 10 




Previous studies have shown biofilm formation for E. faecalis to occur both 
independently and dependent of the Esp presence, suggesting that there are 
other factors determined biofilm formation (Tendolkar et al., 2004, Toledo-
Arana et al., 2001, Kristich et al., 2004). However, when cells have the same 
genetic background, removal of Esp clearly affect biofilm formation and the 
role of Esp in biofilm formation is therefore well-established. Esp also, showed 
an important role in biofilm formation in E. faecium (Heikens et al., 2007). 
Furthermore, it has been shown that Esp is important for the initial adherence, 
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colonization and persistence to gut cells (Heikens et al., 2007, Lund and 
Edlund, 2003). 
All of the studies published so far were based on analyzing the phenotype of 
strains lacking Esp of parts therefore. The true function of Esp is not clear and 
a more biochemical approach is therefore important to study this protein in 
more detail. Here we showed for the first time that purified EspN is sufficient 
to stimulate biofilm formation in cells lacking Esp. Thus, even though Esp is 
unlikely to be an enzyme per se, we have now an assay to measure its activity. 
The purified protein used lacks the C-terminal repeats and cell-wall anchoring 
domain, further corroborating the genetic studies showing that the C-terminal 
repeat domains are not required for its function (Tendolkar et al., 2005). In the 
latter study the N domain of Esp still contained a membrane anchor. 
The membrane anchor is lacking in purified EspN. However, the concentration 
used may be significantly higher than achievable in vivo, which could explain 
that we still observe stimulation of biofilm formation. It is also possible that 
EspN interacts with an as yet unknown partner in the cell wall to enable its 
function. That would confirm earlier suggestions that Esp indeed interacts with 
another component in enterococci, as Esp from E. faecalis is on its own is 
unable to stimulate biofilm formation in Lactococcus lactis, a bacterium that 
does not contain Esp-like proteins (Tendolkar et al., 2005). 
We did not observe that adding EspN to E. faecium cells increased 
hydrophobicity. That was anticipated, as a strain lacking Esp is significantly 
less hydrophobic. However, the hydrophobicity measurements are performed 
in a buffer containing urea and it is conceivable that an interaction of EspN 
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with the components in the cell wall is not very strong and that this interaction 
is disrupted in the presence of urea. However, we have not yet tested other 
buffers or methods for measuring hydrophobicity.  
In conclusion, this study demonstrated for the first time a biochemical test in 
which purified EspN was added to E. faecium strains lacking esp and resulting 
an increase in biofilm formation. This will enable future research to analyze 







































Streptococci are a genus of Gram positive cocci that normally occur as natural 
flora on the skin, in the upper respiratory tract, or in the gastrointestinal tract of 
both humans and animals (Herrera et al., 2009). One of these is Streptococcus 
bovis, which is an intestinal facultative anaerobic bacterium. This organism 
also has been reported as an opportunistic pathogen causing multiple diseases 
such as meningitis, septicemia and endocarditis (Poyart et al., 2002). Recently, 
S. bovis has been classified into three biotypes depending on their ability 
(biotype I) or inability (biotype II) to ferment mannitol. Also, S.bovis biotype 
II has been divided in to biotype II/1 (β-glucuronidase positive) and biotype 
II/2 (β-glucuronidase negative; Rusniok et al., 2010, Boleij et al., 2011a) as 
shown in table 6.1. 
Several studies have shown that endocarditis cases are often linked with 
colorectal cancer (CRC) as first reported by (McCoy and Mason, 1951). Since 
then, several studies have shown full-bowel examination of colon cancer in 
90% cases of patients with S. bovis infections (Vaska and Faoagali, 2009). As 
mentioned before in chapter1, that after Schlegel et al. suggested the new 
nomenclature of S.bovis strains  (Schlegel et al., 2003) (see table 6.1), further 
studies showed that it is mainly S.gallolyticus subsp. gallolyticus being the 
major cause of endocarditis associated with CRC (Vaska and Faoagali, 2009, 
Corredoira et al., 2008). 
Although the association of S. gallolyticus infection with CRC is a major issue, 
the mechanisms behind this link are still unclear (Rusniok et al., 2010). In a 
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healthy colonic environment the host has defence mechanisms against bacterial 
infection through secretion of mucus by Goblet cells to protect the epithelial 
cells and facilitate transit of bowel contents. Also, antimicrobial peptides, 
immunoglobulin A and cytokines secreted by enterocytes, act as protective 
agents against pathogens. However, CRC may lead to changes of physical 
barriers, including increased tight junction permeability and alteration in the 
mucus production and composition. This in turn could make the colon a more 
favourable environment for opportunistic pathogenic bacteria, leading to, for 
instance, increased translocation of the bacteria in to blood stream (Boleij et 
al., 2011a).        
This link between CRC and the virulence of S. bovis strains was studied in 
more detail in a collaborative project (Boleij et al., 2011a) with Dr Harold 
Tjalsma (Radboud University Nijmegen Medical Centre, Nijmegen , The 
Netherlands). The Tjalsma group mainly focussed on host-pathogen 
interactions, whereas we analysed biofilm formation of S. bovis strains as well 









Table  6.1 Nomenclature of Streptococcus bovis Strains. 
New Name Old Name Strains Used in Current 
Study 
S. gallolyticus subsp gallolyticus S. bovis biotype I SB1293,SB 1294, NTB1, 
UCN34 
S. infantarius subsp infantarius S. bovis biotype II.1 NCTC8133 
S. infantarius subsp coli S. bovis biotype II.1 None 
S. gallolyticus subsp pasteurianus S. bovis biotype II.2 None 
S. gallolyticus subsp macedonicus S. macedonicus CIP105685T (SM) 
 
 
The Tjalsma group analysed several factors such as adhesion, invasion and 
translocation using differentiated caco2 cells (colorectal cancer cells). 
Furthermore, cellular immune responses to bacterial infection and bacterial 
surface structure images were analyzed. Strains used in this study were S. bovis 
strains (listed in chapter 2). Pathogenic control strains were Salmonella 
typhimurium (ST) and E. faecalis ATCC19433 (EF), whereas Lactobacillus 
plantarum (LP) and E. coli NTB5 (EC) were non pathogenic controls. 
Figure 6.1 (Boleij et al., 2011) shows the adherence (panel A) and invasion 
(panel B) levels of S. bovis strains to caco2 cells after 2 hours of bacterial 
exposure. Adherence to the colonocyte cells experiment showed that E. 
faecalis has the highest adherence level about 80%. Non pathogenic strains EC 
and LP adhered moderately well (about 20-50%), whereas adhesion of S. bovis 
strains to the epithelial cells varied between strains. However, S. gallolyticus 
(SG) strains showed a low adhesion level compared to those of the other S. 
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bovis strains as well as the commensal LP. Notably, adherence of SG strains is 
similar to that of the pathogen ST, and it was suggested (Boleij et al, 2011) that 
this is a reflection of the inability of SG to efficiently colonise the human gut.  
 
Figure 6.1 Bacterial adhesion (A) and invasion (B) of epithelial cells, see 
text for details, Taken from Boleij et al., (2011a). EC, Escherichia coli; EF, 
Enterococcus faecalis; LP, Lactobacillus plantarum; SG1, Streptococcus 
gallolyticus subsp gallolyticus UCN34; SG2, S. gallolyticus subsp 
gallolyticus 1293; SG3, S. gallolyticus subsp gallolyticus NTB1; SI, 
Streptococcus infantarius subsp infantarius; SM, S. gallolyticus subsp 
macedonicus; ST, Salmonella typhimurium. 
 
After binding to colonic tissues, opportunistic pathogens use different 
mechanisms to cross the epithelial barrier and reach the blood stream. For 
example, Salmonellae can translocate through intestinal epithelial via a 
transcellular mechanism (Ibarra and Steele-Mortimer, 2009), whereas, group B 
streptococci use a paracellular translocation mechanism (Pezzicoli et al., 
2008). A transcellular mechanism would involve invasion. As shown in Figure 
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6.1B, the ST strain was indeed capable of invasion, whereas none of the 
streptococcal strains or other controls were invasive.  To analyze translocation 
capacity of S. bovis strains, the TJalsma group used Caco-2 trans-well cultures. 
Bacteria were added to the apical compartment of the cell culture and after 
incubation the numbers of viable bacteria in both the apical and basolateral 
compartments were counted by determining the colony forming units (CFU). It 
could thus be demonstrated that the SG strains (and in particular SG1), as well 
as the control EF strain were capable to translocation with up to around 19% of 
cells translocating (Figure 6.2). Notably, this was still considerably lower than 
for ST, of which 81% of cells translocated across a Caco-2 monolayer. 
Confocal microscopy experiments (Boleij et al, 2011; appendix A) further 
confirmed these results and showed that there was no passive leakage of cells 
across the monolayer, and it could thus be concluded that S. gallolyticus subsp 
gallolyticus, and to a lesser extend S. infantarius subsp infantarius utilize a 
paracellular mechanism to translocate across a polarized monolayer.  
Figure 6.2 Translocation of indicated bacteria across epithelial monolayer 




Further experiments, figure 6.9, also showed that the SG strains were relatively 
invisible to the immune system as they did not elicit a significant epithelial 
innate immune response (measured through expression of IL-8 and IL-1b), and 
that many cells survived translocation (Boleij et al, 2011 and Appendix A).  
This thus enables the SG strains to enter the blood stream and cause, for 
instance, endocarditis in susceptible patients. In endocarditis, bacteria bind to 
extracellular matrix proteins and form a biofilm to enhance the surviving of 
vegetations on damaged valves (Vollmer et al., 2010). 
Interestingly, the surface structure of SM and SG clearly differ as observed by 
electron microscopy (Boleij et al 2011 and Appendix A). This was further 
corroborated by the complete genome sequence of  S. gallolyticus 
UCN34,SG3, which was recently been published (Rusniok et al., 2010);  the 
sequence identified several genes in an S. gallolyticus operon that encodes 
proteins with a high similarity in sequence and organization with genes 
encoding S. pneumonia serotype 23F surface capsule. Moreover, the S. 
gallolyticus UCN34 genome also encodes other surface proteins that are 
homologous to staphylococcal collagen binding proteins. These four proteins 
are Gallo_0577, Gallo_1570, Gallo_2032 and Gallo_2179. However, only 
Gallo_2179 contains the collagen binding motif (Rusniok et al., 2010). 
Our aim in this part of the project was firstly to test the capability of biofilm 
formation of the streptococcal strains, both on surfaces with and without 
collagen. Furthermore, the aim was to characterise the collagen-binding 
proteins and Gallo_2179 in particular. A final goal was to test the 
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pathogenicity of the streptococcal strains using a simple invertebrate model 
system that makes use of the nematode Caenorhabditis elegans.  
 
6.2. Biofilm formation in S.bovis 
 
   6.2.1 Crystal violet and collagen binding assays 
 
Some of the S. bovis strains can cause endocarditis, which is a biofilm-
mediated infection of heart valves in which bacteria possibly bind to collagen. 
Therefore, biofilm formation assays were carried out in 96-well plates coated 
with collagen I or collagen IV, or without coating. As shown in Figure 6.3, 
initial experiments showed that these strains were not efficient in forming 
biofilms on uncoated plates when compared to an E. faecalis strain (see also 
chapter 4). Interestingly, several S. bovis isolates formed much better biofilms 
in the presence of collagen, and in most cases adherence to collagen I was 
better than to collagen IV. Exceptions were SM, which formed more biofilm on 
a collagen IV coated surface and SI which did not show any difference in 
biofilm formation on the different plates. The non-pathogenic control strain 
LP, a probiotic strain hardly formed any biofilm, irrespective of the presence 






Figure 6.3 biofilms formed by S. bovis strains. SG1, SGUCN34; SG2, SB 
1293; SG3 SG NTB1; SG4, SB 1294; SI, NTCT8133; SM, S. macedonicus; 
EF, E. faecalis ATCC 19433 and LP, L. plantarum. Biofilm formation was 
tested in wells coated with collagen I, IV and no collagen. The error bars 
represent the mean ± standard error. (n=12, *p≤0.05, **p≤0.01). 
 
     6.2.2 Effect of DNaseI on S. bovis biofilm formation 
 
One component frequently found in biofilms is eDNA (see also chapter 4). To 
get an impression whether eDNA forms a part of the EPS in S. bovis biofilms, 
we analysed the effects of DNase on four of the S. bovis strains that form good 
biofilms on collagen I. 100 µl DNaseI was diluted in THB-G medium to a final 
concentration of 100 KU, which was then added to 100 µl of an overnight 
culture and the Crystal violet assay were carried out as usual. As shown in 
Figure 6.4, addition of DNaseI significantly decreased biofilm formation in all 
strains. In SG4 and SG2 biofilm formation were reduced by around 40%, while 





























Figure 6.4 Biofilm formations in S. bovis strains. Strains were treated with 
100 KU DNaseI. The error bars represent the mean ± standard error. 
(n=4, *p≤0.03, **p≤0.01). 
 
 
6.3. Confocal Laser Scanning Microscopy (CLSM) images of 
S. bovis biofilms 
 
To visualize S. bovis strains biofilm formed on collagen-coated surfaces, 
biofilms were grown on “home-made” collagen I pre-coated polyvinyl 
coverslips for 24-hours (see materials and methods chapter). Next, cells that 
adhered to the slides were stained with the dye Syto-9 and analysed with 






















Here we decided to visualize only SG4, which formed the best biofilms on 
collagen I. As a control we also analysed E. faecalis BS385, which had shown 
no difference in biofilm forming in the presence or absence of collagen (see 
chapter 4). 
As clearly shown in figure 6.7, in the presence of collagen I SG4 formed 
efficient biofilm, whereas without collagen only microcolonies were observed 
on the polyvinyl surface. In contrast, E. faecalis BS385 form biofilm in both 
cases.  
 
Figure 6.5 CLSM biofilm formation images for S. bovis SB1294, SG4, and  
E. faecalis BS385 in presence (+) or abcence (-) of collagen I. 
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6.4. Collagen binding protein gallo_2179 cloning  
 
As earlier shown in this chapter, S. bovis strains were observed to form good 
biofilms on collagen-coated surfaces. Recently, a study reported the complete 
genome sequence of S. gallolyticus UCN34, SG1, (Rusniok et al., 2010). The 
strain genome analysis revealed four genes encoding putative collagen binding 
proteins; however, only one of these genes encodes a protein with a collagen 
binding motif, gallo_2179.  Our hypothesis was therefore that this protein was 
essential in biofilm formation on collagen-rich surfaces. As biofilm formation 
of E. faecalis ATCC19433 is not influenced by the presence or absence of 
collagen (see above), it was decided to clone the gallo_2179 gene in this 
organism and test whether presence of this protein could stimulate biofilm 
formation on a collagen-coated surface.  
A 1977-bp long DNA fragment of gallo_2179 was amplified from genomic 
DNA of S. gallolyticus UCN34 using the TaqOne polymerase PCR kit (see 
chapter 2 for primers list). This amplified fragment was cloned into the 
enterococcal expression vector pAT79 using the BamHI and SalI restriction 
sites. The ligation product was used to transform E. coli cells which were 
grown on LB medium supplemented with 60 µg/ml spectinomycin and 5µg/ml 
chloramphenicol. Plasmid DNA was purified, and the correct product (denoted 
pATgallo_2179) was used to transform E. faecalis ATCC19433.  
Biofilm assays using 96-well collagen-coated plate were performed using the 
standard crystal violet staining technique, comparing E. faecalis ATCC19433 
and E. faecalis ATCC19433 (pATgallo_2179). Unfortunately, no differences 
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were observed between the two strains (data not shown). This suggests that 
either gallo_2179 gene is not transcribed in E. faecalis, that its mRNA is not 
translated, or that the gene product is not functional in E. faecalis. To test the 
first option, Reverse Transcriptase PCR (RT-PCR) was performed and the 
result, shown in figure 6.8, revealed that gallo_2179 mRNA is made in E. 
faecalis ATCC19444 (pATgallo_2179). Thus, the remaining options are that 
the protein is either not made or not functional in E. faecalis, but due to time 
constraints this was not further tested. Note also that the RT-PCR technique is 
not quantitative, and it could also be that the quantities of mRNA produced are 




Figure 6.6 RT-PCR results for detect gallo_2179 mRNA. L, DNA marker 
ladder; 1, S. gallolyticus UCN34 positive control; 2, E. faecalis 
ATCC19433; 3, E. faecalis ATCC19433 (pATgallo_2179), see text for 




6.5. Pathogenicity of S. bovis strains 
 
    6.5.1. C. elegans killing assay  
 
In chapter 4, E. faecalis strains showed significant pathogenicity to C. elegans. 
To our knowledge S. bovis strains have never been analysed using this model 
system and it was therefore decided to test this. . Pathogenic controls were the 
enteric pathogens Salmonella typhimurium (ST) and E. faecalis ATCC 19433 
(EF). The non-pathogenic strain used was E. coli HB101 (EC). The data in 
figure 6.5 demonstrate the survival of C. elegans after infection with the S. 
bovis isolates: SG strains, SI and SM.  
Strains, SG1, SG2 and SG4 showing higher nematocidal activity against C. 
elegans with less than 15% survival at day 7. Other strains SI and SG3 also 
shows high level of virulence against C. elegans, with less than 30% C. 









Figure 6.7 C. elegans killing assay for S. bovis strains. EC, E. coli HB101 is 
a non pathogenic control; ST and EF are pathogenic controls, (n=9). 
 
 
     6.5.2. C. elegans anaerobic killing assay  
 
As mentioned previously in chapter 4, pathogens can kill nematodes in a slow 
mode (figure 6.5), or by a fast mode in which pathogens (e.g. E. faecium) can 
kill nematodes through the production of toxic compounds such as hydrogen 
peroxide (Jansen et al., 2002). To test whether S. bovis strains produce 
hydrogen peroxide or other toxic compounds in a similar manner as E. faecium 
E1162 (Meredith, 2013, Moy et al., 2004) bacteria were grown anaerobically 
on BHI plates to form a lawn. The next day C. elegans nematodes were 
deposited on the plates and their survival was monitored. This test was 
performed on selected S. bovis strains which form an efficient biofilm on 



























 Positive control was E. faecium E1162 and the negative control was E. 
faecalis BS385. As shown in Figure 6.6, , after a 2 hour incubation 100% of 
nematodes were still alive on the S. bovis lawns, while at that stage 60% of 
nematodes had died on the E. faecium lawn. Only after overnight incubation 
some death was observed (~35%), to a level similar to that of E. faecalis.  
 
 
Figure 6.8 C. elegans anaerobic killing assay result for S. bovis strains. E. 





























6.6. Discussion  
 
As mentioned in the introduction into this chapter, there is a clear association 
between CRC, endocarditis, and S. bovis. Virulence traits that are involved in 
this have been studied here and by the Tjalsma group. The conclusion of this 
study was that there are four essential steps in establishing endocarditis starting 
from intestinal tract (figure 6.9). 
 
Figure 6.9 Model for the association of SG strains endocarditis and CRC. 
IL, interleukin, Taken from Boleij et al., (2011a). 
 
Firstly, adherence and internalization of enterocytes or its extracellular matrix; 
secondly, paracellular translocation of the pathogenic bacteria through the 
epithelial barrier; thirdly, escaping the innate immune response; and fourthly, 
reaching blood stream and starting a secondary infection such as endocarditis. 
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Figure 6.9 shows a model for S. bovis strains endocarditis associated with 
colon lumen (Appendix 1). As shown previous, that SG strains displayed a low 
adherence to a healthy epithelial cell, however, in carcinoma epithelial cells 
exposed collagen IV which mediates the adherence of these bacteria and other 
pathogens, ST and EF, and translocation via paracellular mechanism except 
SM strain which able to only colonize epithelial cells. Upon infection, SG 
strain has the ability to escape from host immune defense, IL-8 and IL1β, to 
the blood stream. In contrast, pathogen strains such as ST and EF which induce 
immune response. 
It is presently not clear whether S. bovis strains cause CRC, but our biofilm 
studies in which we showed that S. bovis strains form biofilms particularly well 
on collagen-rich surfaces at least indicate why there is this association. One 
possibility is that tumours in the gut merely provide an environment which is 
suitable to growth of S. bovis.  Alternatively, it is possible that lesions in the 
gut provide a niche for S. bovis to adhere and form biofilms, and these might 
than exacerbate the damage leading to development of cancer. Indeed, a 
previous observation by Yantiss et al (2001) (Yantiss et al., 2001), showed that 
early colorectal tumor and polyps are characterized by continuously expression 
of collagen IV in the basement membrane in the mucosa. Thus, opportunistic 
pathogens such as S. bovis would find a good niche and environment to 
colonize and infect the colon, explaining why 10% of the normal population is 
colonised with SG strains, whereas these strains are found in 55% of CRC 
patients (Johansson et al., 2008). 
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It is at present unclear how much damage is created by colonisation of S. bovis, 
but our experiments with C. elegans show that there is sufficient damage in to 
cause death of the nematodes. These experiments also showed that 
pathogenicity of S. bovis strains is more similar to E. faecalis than to E. 
faecium. Firstly, both S. bovis and E. faecalis have a slow mode of killing that 
is absent in E. faecium. Secondly, of the three organisms only E. faecium has a 
fast mode of killing through the production of hydrogen peroxide (which 
accumulates during anaerobic growth; (Moy et al., 2004). 
Upon adherence to tissues in the gut, S. bovis strains may reach the blood 
stream as outlined above. That enables the bacteria to reach other parts of the 
body and again, in particular, adhere to and form biofilms on surfaces that are 
rich in collagen. One such surface is the heart valve, which is rich in collagen 
I, thus explaining the association with CRC and encodarditis (Sillanpää et al., 
2009)..    
Interestingly, SI showed no differences in biofilm level with or without 
collagen, and this strain is not often found in endocarditis(Jean et al., 2004), 
corroborating our hypothesis on the link between collagen-binding and 
endocarditis. The Tjalsma group did observe translocation of SI to the blood 
stream, thus explaining the fact that SI is often found to cause to bacteremia in 
CRC patients(Jean et al., 2004). 
As previously mentioned in this chapter, the full genome sequence UCN34 
strain revealed the presence of  a number of potential collagen-binding proteins 
that are related to the MSCRAMMs family (see chapter 4; Rusniok et al., 
2010). Only one of these (Gallo_2179) contains a putative collagen binding 
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motif (Gallo_2179). We successfully cloned the gallo_2179 gene in an 
enterococcal expression vector, and demonstrated that the gene was indeed 
transcribed in E. faecalis. However, this strain did not form better biofilms on 
a collagen-coated surface, suggesting either that not sufficient amount of the 
Gallo_2179 protein was made, or that the protein is not functional in E. 
faecalis. Insufficient amount of protein could either be due to low quantities of 
mRNA (our RT-PCR demonstrating presence of mRNA is not quantitative), 
inefficient translation of the mRNA, or instability and degradation of the 
protein. Lack of function of the protein could also have several reasons, 
including misfolding of the protein, improper localisation of the protein at the 
membrane, or the lack of a partner protein required for adherence to collagen. 
Further investigation of this would require a substantial amount of work 
including raising antibodies to determine e.g. the levels of protein produced 
and the localisation of the protein. Due to time constrains this was not pursued 















                                                                       































7.1. Final discussion  
 
As mentioned in chapter 3, many virulence factors are secretory proteins that 
either function at the cell wall or in the extracellular milieu. For that reason a 
bioinformatics analysis was performed to identify putatively secreted proteins 
in S. gallolyticus; similar analysis have also been done for E. faecium 
(Meredith, 2013), whereas proteomic studies on extracellular proteins have 
been performed on E. faecalis (Shankar et al., 2012). In the same chapter, 
bioinformatics analysis of the S. gallolyticus genome revealed several secreted 
proteins. A number of those proteins are hypothetical proteins with unknown 
function and it would be interesting to discover more about these proteins. 
Such an approach was also used with E. faecalis, in which a hypothetical 
protein was shown to be a virulence factor involved in pili formation (which 
play an important role in adhesion and biofilm formation; Sillanpaa et al., 
2004).  
Biofilm assays were performed on different E. faecalis strains, showing 
variation in biofilm formation between the strains. Several factors were 
involved in this process for example the presence of virulence factors, 
hydrophobicity and heterogeneity. 
One study showed that E. faecalis with mutations in the fsr-locus or gelE 
resulted in poor biofilm formation. In the same study fsr-only mutants formed 
wild-type biofilm level by addition of purified GelE, suggesting that GelE 
alone could enhanced biofilm formation (Hancock and Perego, 2004). In 
addition, studies on the role of Esp in biofilm formation resulted in 
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contradictory results with some showing that biofilm formation is independent 
from Esp and others showing that Esp is important (Toledo-Arana et al., 2001, 
Tendolkar et al., 2004, Kristich et al., 2004). However, as shown here (chapter 
4), E. faecalis BS12297 is a much better biofilm former than BS11297, while 
both contain Esp, and BS11297 even contains GelE as well. It is thus clear that 
other factors play an important role as well and that capacity to form biofilms 
is not solely determined by the presence or absence of just a few factors.  For 
instance, it has been shown that BS12297 shows more cell culture surface 
charge heterogeneity, which may stimulate adhesion to surfaces, whereas 
cultures of E. faecalis BS11297 are much more homogenous (van Merode et 
al., 2006b). In addition we have shown here also that hydrophobicity plays an 
important role, with the better biofilm formers being more hydrophobic. What 
exactly determines heterogeneity within cell cultures, or the hydrophobicity of 
cells is actually not well understood. For instance, strains lacking Esp are less 
hydrophobic (chapter 5), but Esp is not a hydrophobic protein and it is thus not 
clear why Esp makes cells more hydrophobic.   
  
Other factors may also play an important role in biofilm formation in several 
bacteria the presence of extracellular DNA has been shown to be an important 
factor in biofilm formation. Interestingly, the effect of DNaseI treatment of this 
strain showed only a fairly mild reduction in biofilm formation of E. faecalis, 
indicating that DNA is not a major component of the EPS in E. faecalis isolate.  
 
As several cell-surface proteins play an important role in biofilm formation, we 
analysed the effects of sodium azide; this inhibits ATPases but is particularly 
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active on the ATPase SecA, a central component in the Sec-dependent 
translocation pathway (Miller et al., 2002). As most surface proteins in 
enterococci are predicted to be Sec dependent, it was anticipated that sodium 
azide could be used for preliminary studies into the importance of the Sec 
system in biofilm formation in Enterococcus faecalis strains (Miller et al., 
2002).  Note of course that sodium azide is toxic to bacteria, but enterococci 
are somewhat of an exception as they are relatively tolerant to azide. Adding 
sub-lethal concentrations of sodium azide resulted in a significant decrease in 
biofilm formation of BS12297 (the strain which forms the best biofilms), 
whereas there was a small (but statistically not significant) decrease in the 
other isolates. Also, hydrophobicity was reduced in the presence of sodium 
azide in BS12297 and BS385. Thus indeed it seems that sodium azide 
influences the composition of the cell wall, resulting in a reduced biofilm 
formation. Confusingly, protease production was increased in BS11297 in the 
presence of sodium azide, possibly a stress-response effect, but this strain is a 
very poor biofilm former and azide did not have an effect on biofilm formation 
or hydrophobicity of this strain. 
 The clearest effect on the presence or absence of specific factors was observed 
in E . faecium E1162 and E1162Δesp; here we can compare these strains 
straightforward as both have the same parental background and thus differ only 
in the production of Esp. As demonstrated before, the strain lacking Esp shows 
a significantly reduced biofilm formation, and this strain is also significantly 
less hydrophobic. Here we also demonstrated for the first time a biochemical 
test for a cell surface protein in biofilm formation: addition of the purified N 
domain of Esp (EspN) to E. faecium E1162Δesp resulted in the restoration of 
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biofilm formation. This assay and the availability of purified protein will 
enable the further biochemical analysis on the role of this protein in biofilm 
formation in more detail.  
In chapter 6, we demonstrated the ability of S. bovis strains to form biofilm on 
collagen coated surfaces. This provided an important clue towards the 
pathogenicity of these strains as, for instance, the heart valve is largely made of 
collagen thus explaining the link between endocarditis and S. bovis strains. 
Similarly, this could explain the link with colon cancer, as extracellular matrix 
proteins such as collagen may become exposed in tumours and/or lesions in the 
gut. Whether tumours provide a niche for S. bovis for colonization, or whether 
S. bovis infections of lesions could exacerbate development of such lesions 
into tumours remains to be investigated.   
Recently, a full genome analysis has been identified for S. gallolyticus UCN34 
(Rusniok et al., 2010), and one important protein identified in this was a gene 
encoding a putative collagen-binding protein denoted gallo_2197. Our aim was 
to clone the gene and then test its function in biofilm formation on collagen 
coated surfaces in E. faecalis ATCC19433, a strain in which biofilm formation 
is independent from the presence or absence of collagen. Unfortunately, no 
differences were observed between E. faecalis ATCC19433 and E. faecalis 
ATCC19433 (pATgallo_2179). We did demonstrate (with RT-PCR) that the 
gene is expressed. From that we could conclude that either the quantity of 
mRNA produced is very low (the RT-PCR was not quantitative) or that gene is 
not functional in E. faecalis. The latter could be because of, for instance, 
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improper localisation of the protein, or lack of a protein partner that is only 
present in the parental S. bovis strain. 
 
7.2. Future work  
 
The mechanisms of factors involved in pathogenicity and biofilm formation 
remain unclear in both enterococci and streptococci. In future studies it will be 
interesting to discover more about their roles and whether they interact with 
other factors and for this genetic and biochemical analysis are required. A 
problem is, however, at present the lack of some genetic tools for enterococci 
and streptococci. Some tools are available but, for instance, there is a lack of 
efficient systems for inducible expression of genes. Several factors are of 
interest to study further. In particular the role of Esp is unclear; it is known that 
it is important in biofilm formation, but it is actually not known what it does. 
In this thesis the first tools and assays have been developed that will enable 
further biochemical studies. Understanding the process of biofilm formation at 
the molecular level will provide a platform for the development of new 
strategies for treatment of enterococcal infections, as it is clear that biofilms 
are an important component in the pathogenicity of enterococci.  
For streptococci, the role of the collagen-binding protein is worthy of further 
investigation, as it may be an important virulence factor and thus also potential 
target for drug development. In the near future it should be investigated 
whether the collagen binding protein is indeed produced and translocated 
properly in E. faecalis; if so, we’d anticipate that it requires a binding partner. 
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Co-purification experiments or similar types of assays could then be used to 
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